Podcasts about cures act

Dr. Bryan Laskin joins hosts Dr. Maggie Augustyn, Dr. Chad Johnson, and Regan Robertson to expose the truth about dental data. From HIPAA misunderstandings to unethical software vendors, Bryan breaks down what every dentist must know about protecting their practice, empowering patients, and staying compliant in a post-CURES Act world.

Protect Your Retirement W/ a PHYSICAL Gold IRA https://www.sgtreportgold.com/ CALL( 877) 646-5347 - Noble Gold is Who I Trust   Researcher and activist Jesse Beltran from MindNexusLive.com joins me to share his disturbing deep research which suggests that Americans from all walks of life, citizens, military and inmates are being chipped without their knowledge or consent under Section 3024 of the Cures Act. Welcome to the internet of things where you are no longer classified as "human" and you will be tracked and traced against your will.   Sign the petition to end this evil madness: Stop Non-Consensual Human Testing—Repeal Section 3024 of the Cures Act https://tinyurl.com/3ax3pc73   https://rumble.com/embed/v6qykvv/?pub=2peuz

Send us a textMatt sits down with Angela Arnold-Ross, an Australian genetic counsellor living in New Jersey, for a candid and heartfelt conversation about professional resilience and personal growth in the field of genetic counselling.• Sharing the experience of being laid off after 15 years and the emotional impact of unexpected job loss• The stages of grief following a career disruption and how writing became therapeutic• Using networking to rebuild a career path through connections with other genetic counsellors• Navigating the complex landscape of genetic counsellor licensure across different states in America• How the Cures Act has changed counselling approaches when patients receive results immediately• Personal health experiences transforming professional counselling styles and enhancing patient empathy• The importance of advocating for patients and teaching them to navigate complex healthcare systems• Why accurate medical terminology matters for effective patient communication and appropriate careSupport the showDemystifying Genetics is sponsored by TrakGenehttps://www.trakgene.com/

SummaryIn this episode, Sean and Terry discuss the evolving landscape of healthcare compliance, particularly focusing on HIPAA protections and the implications of the Cures Act. They explore the changes in regulations post-COVID, the importance of safeguarding mental health information, and the need for practices to stay updated with compliance policies. The conversation emphasizes the complexities of navigating healthcare regulations and the necessity for clear communication and understanding within the industry.TakeawaysTerry and Sean both experienced health issues recently, leading to a brief hiatus.There has been a noticeable change in HIPAA protections since COVID, with some practices not updating their policies.Certain medical records, especially in behavioral health, require extra protections under HIPAA.The Office of Civil Rights oversees HIPAA violations, not just Medicare.Explicit consent is required to disclose mental health information under HIPAA.The 21st Century Cures Act has implications for patient access to medical records.There are limitations on disclosing information that could lead to a patient being jailed.Practices need to ensure their staff is aware of updated compliance policies.HIPAA protections extend beyond the office and into patient interactions in public spaces.The healthcare industry is highly regulated, and changes in administration can impact compliance policies.

Learn more about Health Bank One! ▶ http://www.healthbankone.com/Download the Health Bank One app from the Apple App StoreUse code HOEFLINGER for 20% off your monthly subscription.Download the Health Bank One app from the Android App Store In this episode, Dr. Brian Hoeflinger and Kevin Hoeflinger sit down with Bo and Ford Holland, the father-son duo behind Health Bank One. They discuss the critical issue of medical data accessibility and how their personal journey, Ford's battle with a rare brain tumor, led them to create a digital banking system for health records.Bo, a seasoned software entrepreneur, and Ford, a data scientist, share how Health Bank One empowers patients by giving them control over their medical records, streamlining information sharing between doctors, and integrating AI to enhance patient care. They also dive into the impact of the Cures Act, the challenges of modern healthcare data systems, and their mission to revolutionize medical recordkeeping. This conversation will change the way you view medical records, patient care, and the future of healthcare.Disclaimer: Health Bank One is a partner of The Hoeflinger PodcastCheck out My Free Newsletter: pages.doctorhoeflinger.comEach week, I simplify the world of health, medicine, and fitness using my 25 years of experience as a board-certified neurosurgeon. Tune in every week for new episodes of The Hoeflinger Podcast with Dr. Brian Hoeflinger and Kevin Hoeflinger.All Dr. Hoeflinger's linksClick here for all links for Dr. HoeflingerKevin Hoeflinger's linksClick here for all links for Kevin HoeflingerContact Us brian.hoeflinger1@gmail.comThank you all for watching and listening to our content and we hope you continue to follow along on our journey!

In this episode of Quality Matters, host Andy Reynolds delves into the transformative impact of the Trusted Exchange Framework and Common Agreement (TEFCA) on health care data interoperability. Joined by Amol Vyas, NCQA Vice President of Interoperability, and Eric Musser, Vice President of Federal Affairs, the discussion uncovers how TEFCA is reshaping the landscape of health information exchange.Amol explains TEFCA's function as a voluntary, national network (analogous to the postal service in its role as a connector) and highlighting implications for the free flow of HEDIS data. Eric provides insight into TEFCA's bipartisan roots in the Cures Act of 2016, emphasizing TEFCA as a model of public-private partnership and standards-based improvement. Key Quote: “I think TEFCA has kind of been the underdog in health policy for a while now. Value-based care, patient safety, whole-person care, all those things are really salient topics that are brought up a lot. I think TEFCA is about to have its moment and I'm excited to see it come to greater fruition. I'm really happy to see all the progress we've made. It's going to take a full government, full industry approach to make this work for people. I think we're well on our way,”-Eric MusserTime Stamps:(00:28) Understanding TEFCA(01:42) New SOPs and Their Impact(06:36) Public Policy Perspective on TEFCA(10:00) Public-Private Partnership in TEFCA(12:10) Looking Ahead with TEFCALinks:Bulk FHIR Quality CoalitionDigital HubConnect with AmolConnect with Eric

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Gregory Stein, Founder, Chief Executive Officer, and Director of Shadowbox, joins us to discuss how the 21st Century Cures Act could impact interplay within the healthcare industry, particularly interoperability as a means of addressing what has become, according to recent testimony before the U.S. Senate Budget Committee, a $950 billion administrative burden.   What We Discussed in This Episode Why was Shadowbox founded, and how is its technology poised to impact the long tail of healthcare? How have the Cures Act and other recent regulations been a game changer? Where is the IT vendor industry headed in terms of adapting to the Cures Act requirements and interoperability? What are some existing disparities between those inside and outside the regulatory certified health IT framework that could create additional gaps in the industry and the ability to access quality care? Beyond the potential for catastrophic health consequences, what other gaps have arisen as the industry has continued to evolve? How should regulators go about addressing some of these gaps?   About Gregory A. Stein Gregory A. Stein is the Founder, Chief Executive Officer, and Director of Shadowbox, a venture funded healthcare software company whose mission is to elevate patient care by making patient data easy to access and safe to share no matter where it resides. A former legislative aide on Capitol Hill, Greg was an original investor in Millennium Health and previously served as the company's Vice President of Strategic and Community Affairs, helping it grow to over 1,500 employees and $1.8BN in enterprise value.  Beyond the boardroom, Greg has dedicated his career to community service. He co-founded the Safe Homes Coalition to battle prescription drug abuse and served as Chairman of the San Diego County Taxpayers Association for seven years, leading the charge for better government efficiency.   About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.   About Phil Kim A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies. Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil regularly advises clients on matters related to healthcare compliance, including liability exposure, the Stark law, anti-kickback statutes, and HIPAA/HITECH privacy issues. He also provides counsel on state and federal laws, business structuring formation, employment issues, and involving government agencies, including state and federal agencies.   Contact Info Gregory A. Stein Sara Shanti Phil Kim   Resources Shadowbox   Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month.  If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.  

It turns out I was wrong about the 21st Century Cures Act. But only in technical terms, really. The reality of the situation that dental practice owners are in is still a dire one, perhaps even more serious than we previously realized. In this episode of The Patient First Podcast, I explain why we need a correction in our understanding of the federal legislation pertaining to the handling of dental patient information. In short, dentists and DSOs of all sizes are obligated by HIPAA to make patient data accessible to their patients, and the 21st Century Cures Act prohibits actions that unnecessarily limit accessibility to data. I also explain what is currently the ONLY solution that allows dental practices to comply with both HIPAA and Cures Act regulations. Learn what my team and I currently know about patient data accessibility in this episode and follow this space to stay up-to-date with new clarifications. I'm Dr. Bryan Laskin—entrepreneur, author, dentist and advocate for the dental Standards and innovations that will continue to make oral healthcare more efficient, effective and patient-focused. Learn more about the biggest issues fragmenting our industry: DentalDisorder.com Get your practices compliant with the only solution that gives patients access to their own dental data: Toothapps.com

Travel RN Coach (@lindseys_leisures), Lindsey, joins Nurses Uncorked to discuss her recent viral video in which a patient made alarming threats against their former ER nurse at Peace Health Southwest Medical Center. The repeated threats included very specific identifying details of the nurse's family, begging the question, how were they able to find this information?   The answer lies in The 21st Century Cures Act, first passed in 2016. Many medical professionals remain unaware of The Cures Act. And patients often do not understand the complications it poses to their care. Why do patients have access to nurses' full names? Is this a safety risk that employers should mitigate? What role do electronic health records, like Epic, Cerner, or Meditech play? Should patients have real-time access to their medical records? Join us as we break down The Cures Act and it's ramifications.    References: https://www.congress.gov/114/bills/hr34/BILLS-114hr34enr.pdf National Public Radio (NPR): Winners and losers with the 21st Century Cures bill. http://www.npr.org/sections/health-shots/2016/12/02/504139105/winners-and-losers-if-21st-century-cures-bill-becomes-law.    Follow Lindsey: https://www.tiktok.com/@lindseys_leisures?_t=8k1XIaaTQr9&_r=1 https://www.instagram.com/lindseys_leisures?igsh=MTd5Z2tleHdwYXJsbg== https://lindseysleisures.net/ https://youtube.com/@lindseys_leisures?si=LiWRkky8bgNVbera   New episodes of Nurses Uncorked every Tuesday. Help us grow by giving our episodes a download, follow, like the episodes and a 5 ⭐️ star rating! Please follow Nurses Uncorked at!  https://www.tiktok.com/@nurses.uncorked?_t=8drcDCUWGcN&_r=1 https://instagram.com/nursesuncorked?igshid=OGQ5ZDc2ODk2ZA== https://youtube.com/@NursesUncorkedL https://www.facebook.com/profile.php?id=100094678265742&mibextid=LQQJ4d You can listen to our podcast at: https://feed.podbean.com/thenurseericarn/feed. https://podcasts.apple.com/us/podcast/nurses-uncorked/id1698205714 https://spotify.link/8hkSKlKUaDb https://nursesuncorked.com     DISCLAIMER: This Podcast and all related content [published or distributed by or on behalf of Nurse Erica, Nurse Jessica Sites or Nurses Uncorked Podcast is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions expressed or contained herein are not intended to serve as or replace medical advice, nor to diagnose, prescribe or treat any disease, condition, illness or injury, and you should consult the health care professional of your choice regarding all matters concerning your health, including before beginning any exercise, weight loss, or health care program.  If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.   Any information or opinions provided by guest experts or hosts featured within website or on Nurses Uncorked Podcast are their own; not those of Nurse Jessica Sites, Nurse Erica or Nurses Uncorked Company.  Accordingly, Nurse Erica, Nurse Jessica Sites and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions.

In 2021, federal rules from the 21st Century Cures Act mandated that most clinical notes be made available in real-time, online and free of charge to patients. This practice, commonly known as “open notes,” was a significant step towards enhancing medical information transparency–– a vital step in reinforcing trust in the provider-patient relationship. However, it also introduced complexities, raising questions as to what to include in the notes. “The ethical analysis does not always align with the legal analysis, and these are conversations that ethicists are aware of,” Steven Bondi, MD, JD, says. Dr. Bondi, a lawyer turned doctor, is renowned for his expertise on the Cures Act, Open Notes and Electronic Medical Records. He specializes in pediatric medicine at Golisano Children's Hospital and is an associate professor within the Department of Pediatrics at the University of Rochester Medical Center. “I think that knowledge is important, and we need to know what the law says and what its parameters are and when we can use the exceptions,” Dr. Bondi says. Dr. Bondi recommends multiple resources on this topic. He suggests visiting healthit.gov and navigating to their information blocking section for informative FAQs and webinars. He also recommends the Guttmacher Institute as a source for general knowledge around adolescent health and privacy. Lastly, he explains that he was recently a part of the American Academy of Pediatrics' committee on medical liability and risk management where he helped produce a monthly column called ‘Pediatricians in Law.' This episode was recorded at the 2023 American Academy of Pediatrics National Conference and Exhibition. Some highlights from this episode include:  How to navigate difficult situations and avoid labels  The role that ethics play in this discussion Confidentially in adolescents by state Biggest pitfalls and gray areas  For more information on Children's Colorado, visit: childrenscolorado.org    

The passing of the Cures Act in 2016 aimed to empower patients to take control of their health information to make more informed decisions on their care. In this episode, hosts Reed Smith and Chris Boyer discuss two recent studies that cast a light on if this has indeed occurred. THen they are joined by Chris Turner, of HealthBooksPlus, who shares his insights on the modern healthcare consumer and why it's important to empower them with their medical records.  Mentions from the Show: Patient Data Access, Mobile Patient Portals Reach Unprecedented Use Patient Data Access is Insufficient for 60% of Healthcare Consumers Chris Turner on LinkedIn HealthBooksPlus Learn more about your ad choices. Visit megaphone.fm/adchoices

To better understand the newly launched MeldRx product, I sat down to chat with Patrick Schiess, President & CISO at Darena Solutions.  In the video interview below, Schiess shares how the solution works and the problems it solves for developers.  He also shares some insights into the various healthcare standards available and why MeldRx started with FHIR, but how they can support a number of other standards as well (Side Note: Darena Solutions was one of the first implementers of BlueButton 2.0 for HHS and also the first to get certified for the Cures Act for implementing FHIR APIs, so they have a long history in health data standards and sharing). Learn more about MeldRx: https://meldrx.com/ Learn more about Darena Solutions: https://www.darenasolutions.com/ Health IT Community: https://www.healthcareittoday.com/

In today's CRUZAMENTO Podcast, André Correia e Daniel Guedelha talked with Ron DePinho who delves into his contributions to cancer research and innovation, emphasizing the transformative potential of biotechnology in this critical field. His work is dedicated to advancing our understanding of cancer biology, enabling the development of more precise diagnostic tools and targeted therapies. Through his efforts, he aims to revolutionize the way we approach cancer treatment, with the ultimate goal of improving patient outcomes and quality of life. Additionally, Ron de Pinho actively engages in educating influential figures such as the President of the United States and the Pope, advocating for policies that support the advancement of biotechnology in healthcare and sustainability. His dedication to both research and advocacy solidifies his position as a leading figure in the biotech industry. Ronald A. DePinho, M.D. is currently past president and distinguished university professor of The University of Texas MD Anderson Cancer Center. His research has focused on the fundamental mechanisms driving cancer and aging and the clinical application of such knowledge to prevent and treat disease. Dr. DePinho studied biology at Fordham University, where he graduated class salutatorian, and received his M.D. degree with distinction in microbiology and immunology from the Albert Einstein College of Medicine. He performed his residency and postdoctoral training at Columbia-Presbyterian Medical Center. Dr. DePinho's independent career began at Einstein as the Feinberg Senior Faculty Scholar in Cancer Research and an ACS Research Professor. He then joined the Dana-Farber Cancer Institute and Harvard Medical School where he was the founding Director of the Belfer Institute for Applied Cancer Science and a Professor of Medicine and Genetics at Harvard. As president of MD Anderson, Dr. DePinho conceived and launched the Moon Shots Program, a goal-oriented comprehensive effort designed to accelerate declines in cancer incidence and mortality. This initiative has yielded practice-changing advances in cancer and inspired the national cancer moonshot under President Biden. He also elevated MD Anderson's research and graduate programs, recruited many world class faculty including National Academy Members and its first Nobel Prize. To improve cancer care beyond MD Anderson, he launched and assembled a network of cancer institutions in 24 countries, reaching one-third of the human population. As a researcher, he has published over 400 articles, books and chapters that have advanced our understanding of cancer, aging and degenerative disorders which have led to clinical advances including new cancer drugs and diagnostics. His most notable discoveries include elucidation of the core molecular pathway for aging, determination of the basis for the intimate link between advancing age and increased epithelial cancer incidence, establishment of the central role of telomeres in cancer genome instability, discovery of Sin3 and linkage of sequence specific transcription factors and chromatin regulators, demonstration that aging itself can be reversed which led to new therapeutic strategies for aging and age-related diseases including Alzheimer's Disease. To translate these basic discoveries, he founded 9 private and publicly traded biotechnology companies and served as an advisor or director for biotech and large biopharma companies focused on oncology. His public service includes advisory and directorship roles for AACR and the NIH, as well as the Vatican and several countries. He is chairman and co-founder a non-profit, OPA Health (previously, Unite to Prevent Cancer) whose mission is disease prevention in underserved communities. As an advocate, he was a key instigator in the bipartisan bill raising the age of tobacco purchase to 21 (T21) and the bipartisan Cures Act. He is Vice Chair of the BOD for Act For NIH, a non-profit advocacy organization to garner bipartisan support for the NIH resulting in an additional $14.9B to the base budget and restoring the NIH budget following years of inflationary decline. For his fundamental contributions to cancer and aging and to healthcare, he has been recognized with numerous honors and awards. He was named one of the 100 most influential healthcare leaders, according to Modern Healthcare. His honors include the Melini Award for Biomedical Excellence, the American Society for Clinical Investigation Award, the Biomedicum Helsinki Medal, Albert Szent-Györgyi Prize, AACR Clowes Award, American-Italian Foundation Prize, among others. He is a member of the National Academy of Medicine and the National Academy of Science, and a fellow of the American Academy of Arts and Sciences, the American Association of the Advancement of Science and the American Association of Cancer Research. He received Fordham University's McMahon Memorial Award for Distinguished Public Service, honorary degrees from Harvard University and Hofstra University, and the Ellis Island Medal of Honor. For his work to improve the health of Portugal's people, Dr. DePinho was recognized by its president with the highest commendation, the Order of Saint James of the Sword. Other relevant references | Outras referências relevantes: Ron DePinho (website) Lynda Chin (website) MD Anderson Cancer Center (website) Contacts | Contactos: CruzamentoPodcast.com cruzamentopodcast@gmail.com LinkedIN: Cruzamento Twitter: @cruzamentofm Facebook: @podcastcruzamento Instagram: @cruzamentopodcast YouTube: Podcast Cruzamento

As a result of the 21st Century Cures Act, patients in the United States have greater and more immediate access to their care notes. What are open notes, and what is the role of the chaplain in this new paradigm? As we noted in a 2021 webinar, “Healthcare systems are required to make a patient's electronic medical record directly available via secure portal under the Cures Act. This direct access includes all documentation made by healthcare chaplains, including templates with pre-populated check boxes and narrative notes.” How should chaplain notes be included in electronic health information? Join three leading chaplain researchers for a research-informed discussion of the Cures Act, open notes, and what chaplains need to know about how they can document encounters. We are grateful to Transforming Chaplaincy for co-sponsoring this webinar. We are joined by: Jo Hirschmann, Senior Director of Education, Center for Spirituality and Health @Mount Sinai Health System Csaba Szilagyi, Director, Transforming Chaplaincy Paul Galchutt, Research Staff Chaplain, M Health Fairview

Since the beginning of the year, the Office of the National Coordinator for Health IT has rolled out several new updates to existing interoperability frameworks, including the 21st Century Cures Act, Trusted Exchange Framework and Common Agreement (TEFCA) and U.S. Core Data for Interoperability (USCDI) to improve standards that enable better health information exchange. National Coordinator for Health IT Micky Tripathi explains the latest with these frameworks and discusses the implications on areas like artificial intelligence, interoperability, health equity, data security and more.

May 8, 2023: Dennis Joseph, Sr. Director - Product Management & Healthcare Practice Lead at Digital Scientists joins Bill for the news. What are the latest technologies that Digital Scientist is implementing in healthcare, especially as it relates to telehealth, AI, and getting devices connected? What are the current challenges in using AI models in healthcare due to the quality and availability of data, as well as potential biases in the models? What are the challenges in building a comprehensive patient profile, including genomic and ancestral history, and how can this be addressed in the future? What are the potential use cases of ChatGPT in medicine and wellness, and what are the challenges associated with them? Can ChatGPT be used to provide real-time evidence-based recommendations to healthcare providers to improve patient outcomes, and what are the potential risks and benefits of doing so? What are the limitations of ChatGPT in medical record keeping, and how can they be addressed to ensure patient safety?Key Points:Data quality and bias in AI modelsComprehensive patient profilesUse cases of ChatGPT in medicine and wellnessTelemedicine and virtual assistantsPatient safety and reliability of AI recommendationsNews articles:How Tech Leaders Compete In The Battle Of Healthcare AIJonathan Balaban on LinkedIn: Is the Chat GPT honeymoon over?ChatGPT is impressive, but it may slow the emergence of AGIONC proposes new rules for Cures Act implementation, certifications and more | Healthcare IT NewsThis Week Health SubscribeThis Week Health TwitterThis Week Health LinkedinAlex's Lemonade Stand: Foundation for Childhood Cancer Donate

ChatGPTs Summary: Clearly it is not familiar with HIMSS.Auto GPT: A new autonomous version of GPT that layers chat GPT commands with memory. This AI can be given a task and, if put in autonomous mode, it will try to solve the task on its own. It has been used for a variety of purposes, including starting businesses and SEO optimization. Its potential applications in healthcare are still being explored.End of the Public Health Emergency: The end of the public health emergency may lead to less money in the healthcare system, with concerns about Medicaid redetermination and increased charity care. Some provisions have been protected, but overall, there may be less funding available for healthcare organizations.ONC proposes new rules for Cures Act implementation: The ONC has proposed new rules that aim to advance interoperability and reduce the burden of cost. These rules include making the Electronic Health Record Reporting program a condition of certification and expanding exceptions to information blocking regulations.Cigna physicians deny claims en masse without reviewing them: A ProPublica report reveals that Cigna physicians have denied large batches of claims without reviewing them first, potentially saving the company millions of dollars. Patients are encouraged to be vigilant and pursue denied claims.HIMS Conference: The annual HIMS Conference is now focusing more on technology and healthcare, with a shift towards innovation and digital health. The conference now attracts a wider range of attendees, including CHIME members and VC and private equity professionals.

Dr. James Xie and OpenAnesthesia Editor Dr. Jina Sinskey discuss the Cures Act and transparency in medicine.

How much easier would it be if we had instant access to our medical records, especially imaging, so we could make real-time decisions on our care and even get a second opinion in a timely manner? The reality is that although HIPAA mandates our right for access to our medical records, get copies of them, and request chances be made to them, policies differ depending on facility which hinder a patient's ability to get access real-time. Some charge to release the records, asking patients to cover the 'administrative costs.' Some wait until the very last moment to send under HIPAA's 30-day requirement between the time the request was made and honored. Some even take advantage of a one-time 30-day extension, further delaying the release of records. The delay in getting those records could cost life and limb. But there is some light on the horizon with the new Cures Act as well as innovation by entrepreneurs around medical records access. Leading the discussion is Bill Anderson, Advisor to Digicare, which is creating a platform that at its foundation democratizes access to all medical records for the patient across facilities, and even more, using a special algorithm brings the information to life by highlighting key medical terms and offering patients the ability to instantly get them defined and explained. He's also VP of Partnerships for Briya, which allows patients, physicians, and researchers, and data analytics tools to be able to access and make sense of data from any location, in any format, in near real-time. In the last half of the show, a patient shares her story of perseverance with Peripheral Artery Disease (P.A.D.), a chronic circulation issue impacting mainly the legs, that impacts one in five over age 60. Diagnosed and treated at early onset of symptoms such as leg cramps and pain in the buttocks, hips, thighs, or calves, reduces a patient's risk of heart attack, stroke, and amputation.

This episode's guest is Dave Navarro, Senior Director of Data Science for Harmony Healthcare IT, a data management and lifecycle solutions firm. Dave joins the Dish on Health IT host, Ken Kleinberg, and co-host, Jocelyn Keegan,to talk 21st Century Cures Act and the change in the definition of “EHI”, critical components of plans to purge, archive, or transition data to new platforms, and how to marry data in various formats and versions of CCDA and FHIR. Ken kicked off the episode by asking co-host, Jocelyn Keegan, to briefly introduce herself and to share what she's looking forward to learning from today's guest.Jocelyn responded by explaining that she is the payer-practice lead at POCP, devoted to positive change and building/getting stuff done. She went on to say that her focus is on interoperability, prior authorizations, and the convergence of tech, standards, and product strategy. She also serves as the program manager for the HL7 Da Vinci Project. Da Vinci started as a conceptual idea of emulating the great work produced by the argonaut project but with a focus on payers and providers, value-based care, and clinical data interoperability and has become likely the most expansive of the FHIR Accelerators to date, focused on payer-provider collaboration.Ken then asked guest, Dave Navarro to briefly introduce himself and to include his professional background and journey to Harmony Health.Dave reiterated that he is the Senior Director of Data Science at Harmony and that he started his career about 22 years ago in the health IT world. He explained that he started by configuring EHRs and building clinical integrations for financial systems and clinical systems for Cerner Corporation.Dave explained that early on he had a lot of exposure to different data formats and files and that he's been spending the last 17-plus years in the health information exchange world. He landed at Harmony Health to work on the interoperability of legacy data and the legacy data solutions Harmony provides.Ken asked Dave to expound a little more on the work Harmony Health is doing.Dave explained that Harmony helps their clients' archive data from a legacy system or in some cases transition data from a legacy system to a new system.  If data are archived, they must still be in a format that can be managed, accessed, and consumed to inform clinical decisions.Harmony offers the Health Data Archivers solution, which includes extraction services. Clients can also earmark data that they'd like to have posted in their new system.Ken then shifted the conversation by asking how the industry as a whole or different stakeholders in particular view 21st Century Cures differently and whether Dave wishes there was a perspective the industry would share about how they approach compliance.Dave started by admitting that he hasn't read the entire 21st Century's Cures Act but has familiarized himself with the portions related to interoperability. He shared that he believes this legislation is a good thing. Dave pointed out that while it was signed back in 2016, the industry is just now seeing the results.He explained that he believes Cures has pushed the industry towards the adoption of content standards such as USCDI and transmission standards like HL7 CDA and now FHIR. Dave then went on to talk about the data blocking provision explaining that nobody wants to be a data blocker. This portion of the Act helps open the data stream and make data available where EHRs and ultimately patients can view it.Concerning what perspective he wishes the industry would share, Dave explained that it's about FHIR. He realizes that FHIR is a little bit scary to some, but that the industry should be starting with FHIR. Dave explains that one reason he believes this is the relative ease to understand and use FHIR compared to CDA, which has been a bit challenging to figure out. He went on to say that with FHIR, someone can study an implementation guide for an hour and pretty much figure it out. Dave also pointed out the FHIR US Core data set as being a good specification.Dave then went on to explain that while FHIR isn't an architecture guide it can be used to help make architecture decisions when an implementer is getting started. He added that FHIR builds on the work the industry has done on CDA and takes the lessons learned and fixes a lot of what the industry was frustrated by with CDA.Ken asked Jocelyn to share her view of Cures based on her day-to-day work as program manager of Da Vinci Project focused on payer-provider data exchange. Jocelyn expressed that everything Dave said is so incredibly important. From the Da Vinci perspective, she explained that there is an ongoing dialogue about the intersection of and confusion about the year-end USCDI V3 and FHIR R4 capabilities along with everything in the electronic health information (EHI) requirement.  Joce expressed that this is a great example where folks are looking for additional guidance before making new investments. She explained that most EHRs have a big lift to meet that requirement in a meaningful way. Joce continued by saying that FHIR alone isn't necessarily going to get the industry to the semantic interoperability that it's striving for but that if the industry would pick up the FHIR implementation guides in addition to the more advanced workflow guides, the industry would be making progress toward where it wants to be.The group spoke briefly about the expansion of the definition of EHI to expand outside of USCDI V1 and that many stakeholders are not ready to meet the October deadline. Dave pointed out that ultimately every journey starts with one step, and everyone just needs to pick a place to start which ideally would probably be USCDI V3, and start the work.Jocelyn pointed out that by nature stakeholders under regulation want to achieve certification She went on to say that investments were already made in CDA & CCDA and there's lots of CCDA data moving around. She went on to add that the big question is how the industry is going to manage the collision and misalignment of data formats. And how will the industry decide what needs to be codified, and cleansed and what's OK to remain unstructured? There are several stakeholders in the industry that have stood up to say that it's important that data created today needs to be usable and shareable going forward.Dave shared the experience he's had working in the historical archive world. He explained that for the most part, he encounters more organizations simply interested in checking the regulatory and requirements box, but that Cures pushes toward data being structured and codified simply by setting the expectation that patients will be able to access all their data which means that data, even unstructured data isn't going away. He went on to say that even if only minimum pieces of data or data from specific timeframes are migrated to a new system, archives must be able to be queried so a patient can access that data whether it's in the current EHR system or not.  The perpetuity of data required by the info-blocking rule must change the industry's mindset.Ken asked Dave to share some of the surprising or challenging questions from Harmony clients or notable projects. Dave explained that sometimes clients can share their entire database at the start of a project and this is ideal so the Harmony team can go through everything, and it makes extraction a little easier. What is being seen in many of these projects is that as the team goes through and looks for NDC codes, signature lines, problem descriptions, or allergy lists, the data isn't codified. This information will be there as text. For this data to be queried from any archive, it's got to be codified.Dave added that they use the specifications from USCDI and cross-reference them with FHIR US Core. Dave continued to explain in more complex detail some of the data types and mapping that occur to ensure the archived data can be queried effectively in the future. Dave pointed out that as painful as it sounds, he has been through every single element in the FHIR specification for US Core. He expressed how well put together US Core is and it's critical to how they do their work.Ken then asked about how consent is handled during these archiving projects. This led to a robust conversation with Dave sharing that consents get archived if they are found, however the most recent consent on record in the current EHR would likely be applied to how any data pulled from the archive would be shared.The group went on to discuss the complexity of consent and the importance of establishing and maintaining eConsent in a scalable way. Jocelyn pointed out that through the discussions she's had with stakeholders and through her personal experiences, the industry needs to solve this so that patients can manage their consents in a secure, central place so they can update and change their consents based on their changing lives.Jocelyn then shifted the conversation toward the nature of adoption. She explained that she's heard some express resistance to FHIR because they perceive a push to rip and replace everything with FHIR. Jocelyn shared that she and most other industry leaders aren't proponents of that rip-and-replace concept but rather an incremental adoption approach where you adopt and use FHIR in the use cases it can best support and that FHIR can co-exist and interact with other standards. Jocelyn asked Dave to share his thoughts on FHIR adoption.Dave responded by saying that as much as he's been talking about FHIR, he doesn't yet have anyone with FHIR capabilities coming to query and retrieve data. Dave explained that what he has seen are stakeholders on the eHealth Exchange are part of Commonwell and they're familiar with exchanging data via those networks primarily using CDA formats. We start with where our clients are now but it's important to have FHIR capability built in so multiple formats are supported. He went on to say that in some instances you may have an instance where a FHIR API is used to request data in a CDA document. The industry certainly isn't going to be purely FHIR anytime soon if ever.As is tradition, Ken asked Dave to close out the podcast by sharing what he would like to see from the industry.Dave joked that as cliché as it must sound, interoperability is a journey and not a destination. The industry isn't going to fix everything by some policy deadline, and we aren't going to solve everything with just FHIR alone.Dave went on to say that the industry can learn a lot about how to architect their data by examining these standards to help guide those decisions. While FHIR is not intended as a data model, it is a good specification that can inform a well-formed database.Ken thanked guest, Dave Navarro, and co-host Jocelyn Keegan before reminding listeners that they can find and subscribe to The Dish on Health IT podcast on Apple Podcast, Spotify, or whatever platform listeners use to pick up podcasts and that videos of episodes can be found on the POCP YouTube Channel.

In the uncertainty of today's healthcare industry, we must continue to persevere towards our true north.  The moral imperative to improve the quality of care for patients through better care coordination, including those are underserved, can only be achieved by the realities of the digital age. This transformation will require the medical profession to create a modernized Hippocratic Oath that extends to the broader health ecosystem. The proliferation of interoperable technology and digital health tools has the potential to catalyze value-based care delivery innovation and transparency. However, it must come along with an ethical commitment to guide data sharing, integration, and technical processes. True North will ultimately prevail in connecting value-based networks to those most in need; however, it will take continued progress in amplifying the demand signal for value-based care. On the Race to Value this week, you will hear from one of the top healthcare revolutionaries in our country.  We are honored to bring you, the one and only,Aneesh Chopra - the first chief technology officer of the United States who was appointed by President Obama and the Co-Founder and President of CareJourney. In this episode, you will be party to a powerful conversation on the promise of the digital age in healthcare.  You will learn about how health policy and innovation is ushering in a new era of data flow and interoperability, consumer-driven innovation, price transparency, and clinically-relevant analytics for the future of value-based care delivery transformation. Aneesh Chopra also explains why he feels so strongly why ACO REACH will help us reach True North. Episode Bookmarks: 01:30 Introduction to Aneesh Chopra -  - the first Chief Technology Officer of the United States and Co-Founder and President of CareJourney 04:00 The need for the medical profession to galvanize around the immense opportunity to transform care delivery by embracing the realities of digital age. 06:30 Why do we need a digital Hippocratic Oath to transform medicine? 08:00 The gap between patients being seen on a given day and the 98% of the patient panel that are not. 08:30 Designing database queries and algorithms to Identify patients in need of care. 09:30 Creating a compact between analytics communities and physicians to ensure patients are getting appropriate care. 10:45 The self-imposed barriers to technical and semantic interoperability that come from our current FFS model. 12:00 How the HITECH Act manifested in technology gaps, despite widespread EHR penetration. 14:00 “The delay in the demand signal for value-based care resulted in the de-prioritization in the market for interoperability.” 15:30 The regulatory goals of the 21st Century Cures Act to scale interoperability and eliminate information blocking. 16:45 Cures Act regulatory emphasis on population health is now reaching the market. 17:00 FHIR Interoperability Standards will ultimately deliver on the promise of population health through widespread data exchange and API-led connectivity. 18:00 Ensuring value-based care organizations a “plug and play” approach to unify electronic health records. 19:00 The promise of widespread data exchange in value-based care delivery and how it parallels with the consumer banking industry. 20:30 Similarities between Dodd-Frank Act (banking sector) and the Cures Act (healthcare sector) in regard to consumer data protections. 22:30 JPMorgan cutting off access to Mint because screen-scraping was far less secure than API connectivity. 25:00 If value-based care became the dominant delivery model, the industry wouldn't need so much regulatory oversight. 26:00 The Cures Act is beginning to reverse FFS-driven market failures in order to create a much more rational economic model. 27:00 Referencing the opinion piece in STAT by Aneesh Chopra and Seema Verma about the new price transparency regulations in healthcare.

Identify trends in pediatric mental health and the scope of the current crisis.Review the challenges in identifying and managing pediatric patients with mental health care needs.Describe AAP Guidelines for Pediatric Mental Health Screening and best practices.Provide strategies to manage the tension between documentation imperatives - privacy and the CURES Act.

Most pathologists have limited face-to-face interaction with patients. And yet, many patients would benefit from the opportunity to discuss their lab results with a content expert. What can pathologists and laboratory professionals do to connect with the people we serve? How do we make ourselves available to patients and engage them as partners on their wellness journey? On this episode of Inside the Lab, our hosts, Dr. Lotte Mulder and Dr. Ali Brown, Chief Officer of Medical Quality at ASCP, are joined by Dr. Lija Joseph, MD, Medical Director for the Department of Pathology and Laboratory Medicine at Lowell General Hospital, Dr. Jeffrey L. Myers, MD, A. James French Professor of Diagnostic Pathology and Director of Michigan Medicine Laboratories at the University of Michigan, and Ms. Christie Vazquez, MSN, RN, CPN, Pediatric Nurse at Ann & Robert H. Lurie Children's Hospital of Chicago and ASCP Patient Champion, to discuss how patients benefit from talking to pathologists.  Dr. Joseph and Dr. Myers explain what inspired them to create patient-pathologist consultation programs and explore how we might give patients direct access to a pathologist who can interpret their lab results. Listen in to understand how the CURES Act is impacts these programs and learn how to guide patients to trusted online resources when they don't have immediate access to a laboratory professional. Topics Covered ·  Why it's important for pathologists to talk to and connect with patients·  What inspired Dr. Joseph and Dr. Myers to start patient-pathologist consultation programs at their institutions and the challenges of such a program ·  How patients benefit from understanding their lab tests and pathology reports·  Creating pathology reports that are easy for patients to understand·  The stigma of pathologists not being skilled communicators (and what we can do to overcome it)·  Why it's crucial for pathologists to be clear about their area of expertise and refer questions that are out of their scope of practice back to the referring physician·  How the CURES Act is impacting ' patient-pathologist consultation programs Connect with ASCPASCPASCP on FacebookASCP on InstagramASCP on TwitterConnect with Dr. JosephDr. Joseph on Twitter Dr. Joseph at Lowell GeneralConnect with Dr. MyersDr. Myers on TwitterDr. Myers at Michigan Medicine Connect with Ms. VazquezMs. Vazquez on LinkedInMs. Vazquez at ASCP Patient Champions Connect with Dr. Mulder & Dr. BrownDr. Mulder on TwitterDr. Brown on TwitterResources CURES ActASCP Patient Champion Online ResourcesInside the Lab in the ASCP Store 

In this episode hosts Dr. Martin Lustick and Graham Brown invite Chris Emper, NextGen's legislative expert, to discuss the 21st Century Cures Act. Following NextGen Healthcare's Cures Act certification, Chris shares how this milestone law impacts providers and patients. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Following NextGen Healthcare's Cures Act certification, our legislative expert, Chris Emper, joins the NextGen Advisors to discuss how this milestone law impacts providers and patients alike. For more information, read the blog here.

April 7: Today on TownHall, https://www.linkedin.com/in/brett-oliver-md-1b1b6017/ (Brett Oliver), Family Physician and Chief Medical Information Officer at https://www.baptisthealth.com/ (Baptist Health) interviews https://www.linkedin.com/in/michael-adcock-fache-44585411/ (Michael Adcock), VP Population Health at https://www.magnoliahealthplan.com/ (Magnolia Health) about remote patient monitoring, the payer perspective on HIT and payer and provider relationships. Where is RPM headed? Can we make it more than just monitoring? There's a bunch of new big tech players out there. Is there a disconnect between the digital opportunities out there and where the investment dollars are going? How does this relate to bringing EHRs, the Cures Act and interoperability together? And can payers and providers lessen the chasm in healthcare?

Friday on the Stew Peters Show, biotech analyst Karen Kingston joined Stew Peters to detail a nefarious law called the Cures Act, which has empowered a nationwide eugenics agenda by allocating tax payer funds to ‘research' for mRNA, graphene, and other medicinal poisons for the ultimate goal of killing Americans. Dr. Jane Ruby says the latest data dump from Pfizer confirms there was non-existent safety work before conducting their trial, and they've made it impossible to track long-term outcomes by tainting the control group. A whistleblower nurse involved in plasma transfusions raises the alarm another way the vaxxed zombies of the world are poisoning the pure bloods. It's time to make the tyrants pay! Health Freedom Defense Fund founder Leslie Manookian discusses the dozens of lawsuits being waged against the Biden junta and jurisdictions in Idaho for mask and injection injuries from the bioweapon and the subsequent lockdowns. Check out Leslie's work below: http://healthfreedomdefense.org/ And, Christopher Key of Vaccine-Police.com discusses his mission from God to save lives from the jab jackals. He is now facing a jail sentence for his righteous stand against the killer Covid shot. We need patriots everywhere to join him, by calling out the left-wing tyrants in our justice system responsible for this mess. Call Judge TERESA T. PULLIAM and tell her not to violate Chris' Constitutional rights, and force him to wear a mask in court Monday March 21 at 8:30 am. Mel Bailey Criminal Justice Center, Room 406 801 Richard Arrington, Jr. Blvd. N. Birmingham, AL 35203 Phone: (205) 325-5349 Phone: (205) 325-4867 Miranda Gathof - Judicial Assistant James W. Davis - Bailiff Ashley Dickey - Court Reporter Sheriff Pettway: 205-325-5700 Donate to this cause at GiveSendGo: https://www.givesendgo.com/vaccinepolicenews Don't miss a moment of Friday's edition of the Stew Peters Show, live on StewPeters.com Get Dr. Zelenko's Anti-Shedding Treatment, NOW AVAILABLE FOR KIDS: http://zStackProtocol.com Go Ad-Free, Get Exclusive Content, Become a Premium user: https://redvoicemedia.com/premium Follow Stew on Gab: https://gab.com/RealStewPeters See all of Stew's content at https://StewPeters.TV Watch full episodes here: https://redvoicemedia.net/stew-full-shows Check out Stew's store: http://StewPeters.shop Support our efforts to keep truth alive: https://www.redvoicemedia.com/support-red-voice-media/

The Cures Act was intended to give patients free & easy access to medical records, but many are still having trouble. Why is it so hard to access medical records? Carm Huntress (Founder & CEO, Creedo) rejoins the show to discuss how he plans on solving this problem once and for all. Watch this episode on YouTube: https://youtu.be/rKKlCZshz3oSubscribe to CareTalk on your favorite podcast service:Spotify https://open.spotify.com/show/2GTYhbN......Apple Podcasts https://podcasts.apple.com/us/podcast......Google Podcasts https://podcasts.google.com/feed/aHR0...... Follow us on the Health Podcast Network: https://bit.ly/3GlciwjAbout Carm Huntress:Carm is a entrepreneur and strategic leader with over 20 years of experience in startups focused around consumer and enterprise technology. His first web development and hosting company he started while in high school was eventually acquired in 2001. After finishing his degree in electrical engineering at Northeastern University in 2004, he went on to work for PlumVoice, an IVR and voice technology startup, where he ran their network operations. He later was asked to run product development at My Perfect Gig, a Northbridge and Commonwealth Venture start-up. After two years as CTO at Reef Partners, where he ran the technology for a number of portfolio companies, he became CTO at Audiogon.com, the largest high end audio site in the world. He managed the transition of the core technology platform and team for growth. In 2013 he moved to Denver where he founded RxREVU. #caretalkpodcast #thecuresact #medicalrecords #credo #carmhuntress. #healthcare #healthcareindustry #healthcarepolicy #ViVe2022 #healthpodcastnetwork

Recorded on 02/15/22 In this episode, we discuss interoperability in healthcare, or how data can be more easily shared among stakeholders in healthcare. This has been a unique problem in healthcare, but over the last decade efforts have been underway to resolve that problem first through the HITECH Act and then through the 21st Century Cures Act. Most recently, as part of the Cures Act, we've seen the introduction of TEFCA, the Trusted Exchange Framework and Common Agreement, which sets out a number of guiding principles for the establishment of a nationwide health information network. To discuss this topic and more, we are joined by Micky Tripathi, the National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, where he leads the formulation of the federal health IT strategy and coordinates federal health IT policies, standards, programs, and investments. In addition, Eric Assaraf from Cowen's Washington Research Group joins us as well to help host this episode. For Disclosures, click here bit.ly/3cPHkNW

The 21st Century Cures Act (Cures Act) was signed into law on Dec. 13, 2016. The bipartisan legislation has provisions for the development and delivery of drugs and medical devices, acceleration of research into serious illnesses, addressing the opioid crisis, and improving mental health services. High impact provisions relevant to healthcare providers, health IT developers, and patients focus on improving health information access and exchange.In this episode, guest host Melanie Turner, Associate Vice President of Application Services at UAB Health speaks with John Travis, the Vice President for Regulatory Research and Strategy with Cerner Corporation. This episode features perspectives from a Health IT vendor and health care provider regarding the changes that the law requires, focused in particular on the Information Blocking rules recently promulgated by the Office of the National Coordinator for Health IT to support the Cures Act.

Host Justin Barnes, aka @HITAdvisor, continues his Digital Health series with Chief Interoperability & Security Officer at Qure4U, Bradley Dick. They discuss updates to the Cures Act and interoperability of patient information and best practices. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, host Don Hardwick interviews Rita Bowen once again about the CURES Act, interoperability, and what lies ahead in 2022. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

All practices, hospitals, and health systems this is a critical and timely episode. Claire Ernst, Director of Government Affairs breaks down the legislation passed last night by Congress which waived and delayed several looming cuts to Medicare reimbursement for 2022. She covers the PAYGO 4% cuts, conversion factor changes, sequester delays and phased reinstitution, telehealth coverage for 2022 and more! Tune in for essential updates to your 2022 reimbursement outlook!What you'll get out of this episode: What portion of the previously delayed 2021 budget neutrality adjustments were mitigated for the Medicare physician fee schedule conversion factor through CY 2022 The status of the imposition of the 4% statutory pay-as-you-go sequester resulting from the American Rescue Plan Act through CY 2022; The new plan for the reinstatement of the existing 2% Medicare sequester through March 2022 and more! Quotables“Statutory PAYGO has actually never been triggered before for Medicare…we were getting down to the wire and it wasn't getting done” @ClaireErnstJD“Anyone who has a physician office lab would want to pay attention to this, the protecting access to medicare act (PAMA) passed in 2014 basically redid the formula for data reporting and coming up with the calculation for reimbursing labs which led certain labs to face up to 15% in cuts…many of those cuts were delayed for a year by the CURES Act through the end of this year”@ClaireErnstJD“We went from expecting 9.75% cuts in Medicare reimbursement to removing 9% of those cuts” @ClaireErnstJD“There is momentum [regarding audio only telehealth] if it's something that's important to you and your practice, especially if  you are in a rural area, get in contact with your members of congress and provide them that data or those anecdotes you may have” @ClaireErnstJDRecommended Resources MGMA Washington Connection CMS Newsroom Join the ConversationWe want to hear from our RevDivers! Tell us what topics and people you'd like us to cover in future episodes:- Website - Facebook - LinkedIn - Twitter - YouTubeFollow our hosts on LinkedIn:Taya https://www.linkedin.com/in/tayamoheiser/ Kem https://www.linkedin.com/in/kem-tolliver-bs-cmpe-cpc-cmom-1225b115/ Sponsored by: ABILITY Network

Another insurance nerd joins me on the podcast! Rick Garofolo of Practice Mechanics teaches me about the Cures Act - part of me wishes I didn't know anything about it. BUT it's important and we need to be compliant when it goes into effect. We also discussed some hot topics from his classes at the recent American Association of Dental Office Management's Annual Conference. You may be surprised to learn how you should be tracking inactive patients. We talk about chart notes. I hope you get as excited as we did!

The 21st Century Cures Act (or the “Cures Act'' for short) was a federal law passed in 2016 that included various mental health provisions. This law has significant implications on the way we share information with our patients and their families. Published On: 09/27/2021Duration: 17 minutes, 39 secondsRelated Article: "Welcome to the 21st Century Cures Act Information Sharing Rules," The Carlat Child Psychiatry Report, April 2021Got feedback? Take the podcast survey.

Dr. Anders interviews Dr. Iram Fatima, Chief Operating Officer of CareCloud Inc. (NASDAQ: MTBC, formerly known as MTBC). She shares her medical background and story working her way through various roles in medicine to an unlikely transition to the health IT space. They discuss the upcoming implications of the Cures Act and interoperability, the emergence and importance of telehealth in today's changing landscape as well as the necessity for us all to put the patient first, and think like a patient when designing health IT systems. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

One of the hallmarks of practicing medicine in the 21st century is the creation and maintenance of electronic health data.  Although much of the discussion around data is about ransomware, breaches, and EHR systems, that discussion is expanding.  The Office of Civil Rights is in the midst of a right of access initiative to help patients get their medical records.   The CURES Act addresses information blocking.  This marks a change of focus from rules surrounding the protection of medical data to the use and accessibility of that data. In this episode of SoundPractice, Mike Sacopulos interviews Deven McGraw, Chief Regulatory Officer for Ciitizen and former Deputy Director for Health Information Privacy at The Office of Civil Rights. Ms. McGraw will walk us through the rules for and status of Information Blocking. She will also cover the recent Office of Civil Rights' Right of Access Initiative policies surrounding the “Designated Records Set.”  Since HIPAA went into effect in 1996, healthcare providers have been endeavoring to safeguard patient data. After 25 years, prepare to shift your thinking. Join us for a look at healthcare data, patient privacy, and the law. Deven McGrawCo-Founder & Chief Regulatory Officer, Ciitizen.  deven@ciitizen.comLearn more about the American Association for Physician Leadership at www.physicianleaders.org  

This episode is Part 1 of a rebroadcast from the Florida Chiropractic Association conference in Miami FL. Guest: Marc Alba, ED, ILCS Brad & Jay talk with Marc Abla, Executive Director of the Illinois Chiropractic Society, about the new CURES Act. Mr. Abla has spent the last year researching this new topic is very knowledgable about the new act and its impact on the healthcare technology. Brad & Jay helps Marc bring this important topic to the forefront of Healthcare. DO NOT miss this episode! #Techtalkhealthcare, #Learningcanbefun, #nevermisstechtalk, #greatmusicandfun, Listen Next week for Part 2 of this conference with Kayte Eckels of Boodle AI

Jim Nasr, is the CEO of Acoer, a software development company whose vision, and work is all about building useful, usable, real time technologies that are fundamentally targeted at the healthcare industry. Jim was the former chief software architect at the Centre for Disease Control and Prevention (CDC) in the United States. In this podcast we discuss how NFTs and blockchain can be used to empower individual's consent.   What is blockchain? Blockchain is a public infrastructure that should be used within the public context. Blockchain provides transparency, auditability and accountability. Blockchain is a layer of trust that can be used to impute trust between parties who don't trust each other. Jim is keen for blockchain to move past the world of cryptocurrencies and proof of concepts. He wants to make blockchain as practical as possible with real practical solutions.   Challenges of consent Consent is an element of compliance. In the healthcare industry, when you go see your GP, you fill out paperwork to essentially give them consent to your medical health information for all time. For Jim there are a number of issues with that. It's wrong that the patient doesn't always fully comprehend what they're signing, the process is complicated, it has to be done multiple time and the patient has no rights to say they've changed their mind. Jim gives the example that “if you're my orthopaedic surgeon, you should not have access to my mental health information”. There is a double challenge with regards consent. On one side individuals who sign consent forms have no idea what they have exactly signed, what data is shared and where that agreement is. On the other side organisations have limited idea on who signed what agreements, what data was covered and where the agreements are stored. This creates repetition of the process where the individual is repeatedly asked to sign new consent forms. Dynamic consent is the recognition that consent is not a and done concept, it is more dynamic with potential multiple phases for providing consent with the ability to revoke the consent, where the consent may expire after a certain amount of time and where it could be renewed. Dynamic consent is digital which gives it properties to be tracked and monitored.   Data dignity Data has creators like individuals on Facebook, Instagram and Twitter to name a few who create data on those platforms. Essentially, we are implicitly giving those platforms the ability to use this data and along the way we become the product for the “free usage” of that platform. Consumer of those platform are creating content for the platform to leverage in a manner that creates a financial windfall for themselves. The issue is that we as consumers have no say in how that data is marketed and no say on whether firms like Cambridge Analytica use our data and create secondary data markets for themselves.   Regulation: GDPR & CCPA Regulation such as GDPR (General Data Protection Regulation) and CCPA (California Consumer Privacy Act) provide an important opportunity for regulators to help regulate consent. GDPR gives EU citizens the right to grant access to their information to third parties, including consent and gives them the right to be forgotten. Crucially this regulation carries some serious teeth where the financial penalties for firms who breach GDPR regulation is up to 4% of gross revenue. For example Google has received a fine of €50m, British Airways of €22m and Marriott International of €20m. CCPA is very similar to GDPR in terms of the protection it provides to consumers, in terms of consent and in terms of being fined if firms don't comply. In the healthcare industry there is the Cures Act which gives patients the legal right to get access to their health data from their electronic health record irrespective of the type of app they're using.   Components of consent There are multiple components to a consent.

In this episode of Digital Transformation acceleration with APIs, Vik and Jimmy discuss the basics of API and its impact on digital transformation in health systems.The biggest factor for talking about APIs in healthcare is digital transformation. COVID has accelerated digital transformation in healthcare, it started with telehealth, but it is way beyond just telehealth: increased use AI and machine learning, patient or provider facing mobile apps, analytics, and remote monitoring. As a CIO or CEO of a health system,  you need to be ready for digital transformation.Healthcare has been working on digital transformation however COVID has expedited and pushed health systems to make changes, plus the government is also pushing digital transformation with CURES Act.Vik and Jimmy use examples from other industries to show user experiences are way better compared to healthcare.From a CIO standpoint, it starts with strategy, to enable digital transformation, you need to make it easier for data sharing for AI, Machine Learning, mobile apps, remote monitoring. And API is the way to go compared to the traditional way of integration. Vik and Jimmy then dive into specifics about strategy and use a practical example to explain how APIs need to be implemented.APIs also help realize significant ROI (return of investment) over traditional integration because of reduced resource time for implementation.Vik and Jimmy then dive into on-premise vs cloud for API implementations. Vik explains using FHIR specification for healthcare APIs.Vik explains the competitive advantage of having APIs to enable better user experiences.Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Music Provided by Soundstripe.comLinkedin: Vik PatelLinkedin: Jimmy KimSupport the show (http://www.thisweekinhealthtech.com/)

The past eighteen months has seen an unpredictable level of federal financial support for healthcare providers. Provider Relief Funds and Employee Retention Tax Credit has assisted healthcare providers coping with decreased revenue resulting from the pandemic. In this Bonus episode we will talk with Domenic J. Segalla, Principal and Market Leader of Withum's Healthcare Advisory Group. Domenic will identify currently available federal funds and the terms of qualification for these funds. This bonus episode has a short shelf life as federal programs expire. Don't miss out on opportunities to receive additional federal funds. Join us for expert advice from Domenic Segalla on the methods to receive significant additional dollars under the CURES Act. Domenic J. Segalla Principal, Market Leader, Withum Healthcare Advisory Services http://www.withum.com dsegalla@withum.com Learn more about the American Association for Physician Leadership at www.physicianleaders.org  

Wander through he recent episodes with Jamie and Sarah as they answer YOUR questions and clarify some tricky topics.

Each month, EMedHome.com presents EMCast, the 90-minute podcast hosted by Dr. Amal Mattu, the premier educator in Emergency Medicine.  Subscribe to EMedHome.com for an array of clinical content that will impact every shift.  This month's EMCast covers:(1) Atrial Fibrillation(2) ESC Non-STE ACS Guidelines(3) The Cures Act

Terry Fletcher returns with reasons to implement and update your IT to have true Interoperability for patient-centric care: Cloud access, IT upgrades, ease of Prior Authorizations, and new CURES Act patient access will all be part of being prepared. Terry also discusses the COVID pandemic and the homeless population. Where is the data? SDoH must […] The post 5 Tips to True Interoperability and SDoH links to COVID appeared first on Terry Fletcher Consulting, Inc..

For this episode of Health+Tech, join Lauren Riplinger, vice president of policy and government affairs at AHIMA, and McGuireWoods healthcare partner Janice Suchyta, who co-leads the firm's digital health group. Discussion will cover the following topics: The new Cures Act patient access rule and how to comply with the open notes requirements Trends in health information interoperability among healthcare entities Compliance needs for information-blocking rules and exceptions

Host Jim Tate talks to Jim Hammer, the VP of Operations and Product Development at Harmony Healthcare IT. He’s been in the health IT industry for 20+ years and offers a wealth of knowledge pertaining to legacy data management and 21st century Cures Act compliance. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of This Week in Health Tech we welcome our very own and close friend Wayne Che to talk about Health System and Mobile Apps - Management, Resources, Build vs Buy, Testing, Infrastructure, Security, Privacy, and more!This episode aligns well with the new digital product offering of Tido Inc. for the management of mobile and web apps for health systems. Wayne Che works in multiple roles, primarily as CTO of Sowingo Inc., and has tons of experience with the implementation of mobile apps.We get right into mobile development by starting the discussion on build vs buy.Vik comments that health systems main focus is improving patient outcomes and it does not make sense to assemble a development team in-house. Wayne agrees that you gain speed of execution and plus allows you to focus on the primary job of using IT for providing better care of patients.Jimmy asks what to look for in the development shop and Wayne thinks that you need to have a partner that understands requirements and helps to define requirements. Also, the shop should not only have development skills but it is also more important to have management skills to keep the app updated and continuously test to provide the best user experience.Vik comments that Tido Inc. launched a new digital package to help health systems manage apps and includes custom development of apps. It also includes test automation and maintenance. Wayne indicates that testing and maintenance is a key component otherwise with iOS or android updates app may stop working.Vik and Jimmy then dive into test automation and the importance of testing on actual real devices. This is where real device testing comes into play. Both Vik and Wayne recommend the selenium framework with real device cloud providers like Sauce Labs or BrowserStack.Testing helps provide the best user experience and it is so crucial for patients who may be already going through a lot and a frustrating app experience just adds to negative patient satisfaction.The group then discusses infrastructure for apps. There are many cloud providers and what is the best approach for health systems.Wayne comments that cloud providers do several things well including staying compliant with HIPAA and PHIPA. Vik comments that using the cloud has another benefit which is to reduce traffic from mobile devices directly into the health system network.The group then talks about using APIs for data sharing for mobile apps. Also with ONC's Cures Act, it is required that there are no more data silos, but most health systems should go beyond Cures Act for bidirectional data flow securely.Wayne comments that this is where health systems should look into hiring the expertise for API development and management and ensure security.Jimmy asks the question of why this urgency of APIs and mobile development now? Wayne and Vik respond that not only Cures Act but from providing the best user experience, health systems have to provide APIs and app support.Group then talks about the hybrid approach for mobile app development where you have some expertise in-house, maybe a product owner or architect but use an outside development company.Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Wayne Che: Wayne CheSowingo Inc: https://sowingo.com/Music Provided by Soundstripe.comSupport the show (http://www.thisweekinhealthtech.com/)

In Episode 7 we talk extensively with Dr. Don Rucker who recently finished serving as director of the Office of National Coordinator (ONC). We discuss his unique background which prepared him for this position, the role of the ONC in healthcare, his accomplishments while serving the ONC, the impacts of the HITECH Act and Cures Act, Big Data, and much more. Join us as we delve into this fascinating blend of technology and healthcare.

New federal law gives patients access to almost everything in their medical record, including clinical notes.

This week’s CodeCast focuses on the 21st Century Cures Act or the “Information Blocking” regulations. The regulation became effective last Monday, April 5th, so you must know what is necessary when a patient requests their records and how you could get into monetary trouble if not compliant with their request. Also, when coding for Atherosclerotic […] The post Information Blocking: Cures Act 2021 appeared first on Terry Fletcher Consulting, Inc..

Shaefali and Alice review key components of the Cures Act Final Rule that went public on April 5th, 2021, including  changes to our documentation structure and what to look out for in the future. As always, PedsAdmit aims to inform but is not a substitute for consulting your informatics department or formal legal advice.

Welcome to The Barrier Breakdown: Disrupting Mental Health! This week we are joined by Steve Oneill, the Open Note specialist in behavioral and mental health, faculty at the center of bioethics at Harvard medical school, and adjunct assistant professor at Simmons university. He is interested in how the transparency of Open Note writing in behavioral health can foster trust and partnership, patient engagement, and can even destigmatize mental health. As a component of the Cures Act, Open Notes was supposed to go live last November, but now it's beginning on April 5th! Listen in to find out the timetable for these changes, the scope of the notes that will be made open, and the ethical and legal concerns of omissions. For more information on Open Notes and the Cures Act, head to https://www.opennotes.org/  All our upcoming continuing education events can be found at www.cbicenterforeducation.com You can watch or listen to The Barrier Breakdown on any of the following streaming services: Youtube - https://www.youtube.com/channel/UCyc6xZzY7ra3L5pI2g5GKrw   Podbean - https://cbi.podbean.com  Spotify - https://open.spotify.com/show/2ETgUdDykWN96Tv26PWyZ2  Apple Podcasts - https://podcasts.apple.com/us/podcast/the-barrier-breakdown-disrupting-mental-health/id1546097545  Follow us on social media:  CBI: https://www.facebook.com/CognitiveBehaviorInstitute  Center for Ed: https://www.facebook.com/CBIcenterforeducation  Instagram: @cognitivebehaviorinstitute  Twitter: CBI_Pittsburgh :::::::::::::::::::: Music: Basic Majesty - Ashley Shadow Support by RFM - NCM: https://youtu.be/XVwlTTMgw5c  ::::::::::::::::::::

With the implementation of the 2016 Cures Act, there are big changes coming to healthcare. One of those changes include increasing patient access to their healthcare information. Soon patient notes will be available via online portals. This is an incredibly huge adjustment for physicians and providers who are used to writing notes that are read only by other healthcare workers. In this episode I discuss several ethical issues related to open access to patient notes. I also review some recommendations from the American Academy of Family Physicians for how to prepare for these changes. Through Ethically Sourced, I that generating discussions on Clinical Medical Ethics and Culturally Competent Care will have a positive impact on the lives of patients that look like me. --- Send in a voice message: https://anchor.fm/blackdoctorspodcast/message Support this podcast: https://anchor.fm/blackdoctorspodcast/support

Implementation of the 21st Century Cures Act is set for Monday, April 5. In a nutshell, the legislation directs providers to cease all efforts of information blocking with respect to their electronic health records (EHRs), and to encourage and promote interoperability, allowing for communication and cooperation with third-party application program interfaces.With respect to portions of clinical notes, there appear to be certain exceptions where physicians can block access, including psychotherapy notes, HIV testing results, and any notes that, in a physician’s judgement, could cause harm to an individual. Reporting our lead story on this topic during the next edition of Talk Ten Tuesdays will be nationally recognized professional auditor and coder Terry Fletcher.The live broadcast will also feature these other segments:Outpatient CDI Report:  Colleen Deighan, senior consultant with 3M, will conclude her exclusive three-part series for ICD10monitor and Talk Ten Tuesdays on outpatient clinical documentation improvement (CDI), reporting on measures that require abstracting.Coding Report: Laurie Johnson, senior healthcare consultant with Revenue Cycle Solutions, LLC, will report on the latest coding news and will also conduct the Talk Ten Tuesdays Listeners Survey.News Desk: Timothy Powell, compliance expert and ICD10monitor national correspondent, will anchor the Talk Ten Tuesdays News Desk.TalkBack: Erica Remer, MD, founder and president of Erica Remer, MD, Inc. and Talk Ten Tuesdays co-host, will report on a subject that has caught her attention during her popular segment. 

Healthcare IT Today recently sat down with Sue Chamberlain, MSCTE, RHIA, CCS-P, CDIP, VP, Compliance and Education at RRS Medical, to talk about these nuances and differences. We also talk a bit about how COVID-19 and the coming Cures Act has impacted and will impact release of information. As more patients are getting access to their health data, we also discussed the risks patients should consider as part of these new data sharing regulations. Plus, we talk about the role of HIM in these new regulations and what an HIM professional should do to make sure they and their organization are prepared. Learn more about RRS Medical: https://www.rrsmedical.com/ Find more great health IT content: https://www.healthcareittoday.com/

In this episode of Digital Transformation acceleration with APIs, Vik and Jimmy discuss the basics of API and its impact on digital transformation in health systems. The biggest factor for talking about APIs in healthcare is digital transformation. COVID has accelerated digital transformation in healthcare, it started with telehealth, but it is way beyond just telehealth: increased use AI and machine learning, patient or provider facing mobile apps, analytics, and remote monitoring. As a CIO or CEO of a health system, you need to be ready for digital transformation. Healthcare has been working on digital transformation however COVID has expedited and pushed health systems to make changes, plus the government is also pushing digital transformation with CURES Act. Vik and Jimmy use examples from other industries to show user experiences are way better compared to healthcare.From a CIO standpoint, it starts with strategy, to enable digital transformation, you need to make it easier for data sharing for AI, Machine Learning, mobile apps, remote monitoring. And API is the way to go compared to the traditional way of integration. Vik and Jimmy then dive into specifics about strategy and use a practical example to explain how APIs need to be implemented. APIs also help realize significant ROI (return of investment) over traditional integration because of reduced resource time for implementation. Vik and Jimmy then dive into on-premise vs cloud for API implementations. Vik explains using FHIR specification for healthcare APIs. Vik explains the competitive advantage of having APIs to enable better user experiences. Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Music Provided by Soundstripe.comLinkedin: Vik PatelLinkedin: Jimmy KimSupport the show (http://www.thisweekinhealthtech.com/)Associated Links: https://www.mulesoft.com/resources/api/leveraging-digital-transformation-rightSupport the show (http://www.thisweekinhealthtech.com/)

Brad & Jay talk with Marc Abla, Executive Director of the Illinois Chiropractic Society, about the new CURES Act. Mr. Abla has spent the last year researching this new topic is very knowledgable about the new act and its impact on the healthcare technology. Brad & Jay helps Marc bring this important topic to the forefront of Healthcare. DO NOT miss this episode! #Techtalkhealthcare, #Learningcanbefun, #nevermisstechtalk, #greatmusicandfun, @TechTalkHealthCare, @Infinedi, @Kaizenovate, @ILChiro

Eric Rosow, CEO and Co-Founder, Diameter Health shines light on the new ONC Cures Act and the significance of the Patient Access rule that mandates interoperability technology standards for payers.  The primary purpose of the interoperability rules is to enable patients to have secure access to their own health data.  The rules also establish the Fast Healthcare Interoperability Resource (FHIR) a standard to facilitate working with clinical data often characterized by inconsistency and presented in a variety of formats. @diameterhealth #Optuminsight. #healthdata. #FHIR. #HL7 DIameterHealth.com Listen to the podcast here

Eric Rosow, CEO and Co-Founder, Diameter Health shines light on the new ONC Cures Act and the significance of the Patient Access rule that mandates interoperability technology standards for payers.  The primary purpose of the interoperability rules is to enable patients to have secure access to their own health data.  The rules also establish the Fast Healthcare Interoperability Resource (FHIR) a standard to facilitate working with clinical data often characterized by inconsistency and presented in a variety of formats. @diameterhealth #Optuminsight. #healthdata. #FHIR. #HL7 DIameterHealth.com Download the transcript here  

Our first podcast episode of 2021 features distinguished guest Steve Posnack, Deputy National Coordinator for Health Information Technology for The Office of the National Coordinator (ONC). Our new host Ken Kleinberg along with co-hosts Jocelyn Keegan and Pooja Babbrah talk with Steve about the administration transition, FHIR, moving to APIs in healthcare and the mission to achieve interoperability.  Ken first asks Steve what he expects to see from the Biden administration, more specifically, how that transition will impact ONC and Centers for Medicare & Medicaid Services (CMS) moving forward. Steve says we were set forward on a course related to the 21st Century Cures Act and there is still more to be done in implementing the statutes. Health IT has largely received bipartisan support. The technology work and how technology can be used to support healthcare to make it better is something he believes everyone is passionate about. Steve's points echoed an expected continuity of cross-party support toward areas like health IT, health data and improving the overall functioning, effectiveness, and outcomes of our nation's healthcare system through the use of technology. He did, however, expect to see a greater focus on pandemic response with the Biden administration.  Ken transitions to the next topic and asks Steve and our co-hosts to give their thoughts on how we will see APIs and the work of FHIR accelerators used to support the COVID response and management of the pandemic moving forward. Steve notes the event Accelerating APIs in Healthcare: A Year in Review and Momentum for 2021 that took place on December 1, 2020, which highlights the accomplishments of four years of initiatives, investments and industry participation. He sees opportunity to continue to reduce burden and automate processes as well as work to enrich the point of care through the use of technologies and tools.  Jocelyn points out that the impact of COVID, and the pandemic in general, falls into two classes when it comes to advancing APIs. We've seen some folks pull away from their progress toward value-based care due to delays in compliance dates. However, then we see some people who are no longer waiting on vendors and are understanding the role of APIs. There's nothing else that could have happened to further splay open the current state we tolerate as members of the United States' health system in terms of lack of interoperability. She says it's not about ripping out or replacing old standards, but rather, identifying where we can leverage APIs and tools we get out of FHIR to be able to sew together all these disparate parts.Pooja notes an important topic gaining attention during the pandemic: advanced care planning. People are ending up in the ER or getting intubated. It's not easy for providers to get that information for people who are ending up in the hospital. These patients may have a do not resuscitate or do not intubate order in place. It's not just the HL7 FHIR accelerators that are taking what everyone is doing around these FHIR APIs, but we're taking that and applying it in other areas.  Ken asks Steve what other stakeholders who have not traditionally been involved in ONC's rulemaking will be included in future efforts. Steve says ONC's footprint is widely expansive as his office is the cross section of healthcare as a whole. The Cures Act touched on pediatrics a little bit more heavily and we've been putting out some resources in that regard. Long term post-acute care was another place that was ineligible for incentives under the original HITECH Act money. Then we have everything in between such as behavioral health, mental health, other types of specialty care that are trying to connect to your home base (primary care physician, hospital or ADT notifications). We want to make sure the care community serving patients is aware of what's going on. All of this relies on data and interoperability. Steve also mentions that pharmacy efforts around electronic prior authorization and support for opioid care and management of medication are exciting areas of work as well.An interesting topic, Ken asks Steve how industry participation helps drive ONC's rulemaking. Steve explains that most all his office's efforts are focused on longer-term visions to make lasting change, which means building relationships and establishing trust with stakeholders is essential. He says we can't regulate our way out of everything, but rather, we must get everyone on board for the same mission. Steve notes the importance of seeking knowledge from industry colleagues. Pilot testing and standards performance testing are a vital part of the process, yet he finds that it is sometimes difficult to find stakeholders to back investments.Jocelyn brings up the issue of incentivizing  people so they want to become early adopters. How do we lift the ceiling for those who really want to innovate? She poses a question to Steve asking how they go about making sure that standard ceiling is lifted while at the same time making sure people are meeting the requirements of the floor. He responds by saying this is an issue they have been chipping away at for some time. It's difficult form an interoperability perspective because if two people are at very different levels, sometimes is okay, but other times there is a hard break resulting in friction. As long as it doesn't create a discrepancy in interoperability, we will allow communities to move forward with standards on a voluntary basis once their other requirements are met.  To finish the podcase, Steve leaves us with an honorable mention to Project USA, something to look out for in the coming year, as well as a nod to the continuation of TEFCA and the 21st Century Cures Act in 2021.Pooja's final comments commend Steve for bringing up pharmacy. She notes there actually is a lot of work coming out of ONC that supports the pharmacy-side of healthcare. She advises her fellow colleagues in pharmacy to pay attention to the happenings of ONC and utilize them as a stakeholder in the coming year.Jocelyn ends the podcast by saying she would like to see what momentum will look like on the existing proposed rules once the dusts settle, especially with the delay around the information blocking rules themselves and what will the industry need to do to keep things moving forward.  

In this episode of Bowel Sounds hosts Dr. Jennifer Lee and Dr. Jason Silverman talk to NASPGHAN’s recent Secretary-Treasurer, Dr. Jeannie Huang. We discuss best practices for the transition from pediatric to adult-centered care in pediatric inflammatory bowel disease. We talk about the Doc4Me app to help adolescents find adult gastroenterologists and how the electronic health record can be used as a tool to engaged and help facilitate transition of care. In a special event for this episode, we are partnering with Monday Night IBD, a weekly Twitter chat. Be sure to follow on Twitter at 4pm Dec 14 where there will be a discussion on transition from pediatric to adult GI for IBD patients moderated by Dr. Eric Benchimol. On Wednesday there will be a separate discussion from the patient/parent perspective. We look forward to you joining!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Produced by: Jennifer Lee Special requests: Thank you to everyone for listening to our podcast. If you enjoyed this content and thought it was useful, we ask you to consider doing any or all of the following three things:Tell one person that you think would like this type of content about the podcast. We want to reach more GI doctors and trainees as well as general pediatricians, pediatric residents and medical students.Leave a review on Apple Podcasts -- this helps more people discover our podcast.You can also support the show by making a donation to the NASPGHAN Foundation via the link below.Support the show (https://www.naspghan.org/content/87/en/foundation/donate)Support the show (https://www.naspghan.org/content/87/en/foundation/donate)Support the show (https://www.naspghan.org/content/87/en/foundation/donate)

In this episode of This Week in Health Tech we welcome our very own and close friend Wayne Che to talk about Health System and Mobile Apps - Management, Resources, Build vs Buy, Testing, Infrastructure, Security, Privacy, and more!This episode aligns well with the new digital product offering of Tido Inc. for the management of mobile and web apps for health systems. Wayne Che works in multiple roles, primarily as CTO of Sowingo Inc., and has tons of experience with the implementation of mobile apps.We get right into mobile development by starting the discussion on build vs buy. Vik comments that health systems main focus is improving patient outcomes and it does not make sense to assemble a development team in-house. Wayne agrees that you gain speed of execution and plus allows you to focus on the primary job of using IT for providing better care of patients. Jimmy asks what to look for in the development shop and Wayne thinks that you need to have a partner that understands requirements and helps to define requirements. Also, the shop should not only have development skills but it is also more important to have management skills to keep the app updated and continuously test to provide the best user experience. Vik comments that Tido Inc. launched a new digital package to help health systems manage apps and includes custom development of apps. It also includes test automation and maintenance. Wayne indicates that testing and maintenance is a key component otherwise with iOS or android updates app may stop working. Vik and Jimmy then dive into test automation and the importance of testing on actual real devices. This is where real device testing comes into play. Both Vik and Wayne recommend the selenium framework with real device cloud providers like Sauce Labs or BrowserStack. Testing helps provide the best user experience and it is so crucial for patients who may be already going through a lot and a frustrating app experience just adds to negative patient satisfaction. The group then discusses infrastructure for apps. There are many cloud providers and what is the best approach for health systems. Wayne comments that cloud providers do several things well including staying compliant with HIPAA and PHIPA. Vik comments that using the cloud has another benefit which is to reduce traffic from mobile devices directly into the health system network. The group then talks about using APIs for data sharing for mobile apps. Also with ONC's Cures Act, it is required that there are no more data silos, but most health systems should go beyond Cures Act for bidirectional data flow securely. Wayne comments that this is where health systems should look into hiring the expertise for API development and management and ensure security. Jimmy asks the question of why this urgency of APIs and mobile development now? Wayne and Vik respond that not only Cures Act but from providing the best user experience, health systems have to provide APIs and app support. Group then talks about the hybrid approach for mobile app development where you have some expertise in-house, maybe a product owner or architect but use an outside development company. Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Wayne Che: Wayne CheSowingo Inc: https://sowingo.com/Music Provided by Soundstripe.comLinkedin:

Chapters: (0:00) Introduction (1:04) Why should we care about the Cures act (5:46) What notes are eligible for sharing (10:40) Use of abbreviations (14:02) Liability Concerns (16:09) Tips and suggestions for writing notes

Learn more about the information blocking portions of the CURES Act, set to take effect in April 2021.

With all that 2020 has brought, the Information Blocking Rule that came out of the Cures Act was under the radar of many hospices. Thankfully, HHS extended the compliance date for the Rule to April 5, 2021, from November 2, 2020. With this additional time, hospices need to evaluate how they will achieve compliance; what policies they need to update; the work they need to do with their EMR vendor; and their rollout to patients, families and staff. In this conversation, Husch Blackwell's Meg Pekarske is joined by colleagues Wakaba Tessier, Tracey Toll and Kelsey Anderson to gain their insights on these questions and more.

We have our first physician on This Week in Health Tech. Dr. Michael Farmer, Cardiologist and founder of Corverix to talk about wearables. Michael got into wearables because he found current healthcare very reactive and not enough on prevention. It became frustrating and Michael found that patients had access to smartwatches and all the indicators captured on these devices going wasted. Patients used to fax ECG from apple watch to his clinic. Vik agrees that it is absolutely after the fact medicine but we should be getting to more active caring of patients. Value-based care will incentivize prevention and wearables and value-based care align quite well. Michael indicated that there is a huge return on investment for organizations that recommend wearables for employees. For example, 50% of the US population suffers from high blood pressure and if even lowered blood pressure for 10% of the population using wearables would be a huge benefit. Vik brings up the point that there are massive amounts of data collected by wearables so how do you go about deciphering so much data and presenting it to the provider where it is actually useful. Michael indicated in a perfect world, it would very useful to have a link in the EMR that would present him with all the data points from wearables. For example sleep time, exercise time, etc. Because a lot of times the information you get from patients is not accurate so from a provider perspective it just helps to see actual data points collected in the last few months to make informed decisions. Michael, Vik, and Jimmy then dig into more details about wearable data points like heart rate variability and how they help a physician. Next, they talk about the limitations of EHR and how the data presented in a standard EHR is not easy to use and there is usually way too much going on instead of presenting crucial data points in a visual manner. The other huge advantage of wearables is provided personalized care for patients. Vik then mentions the strategy they use for digital apps integration. Instead of traditional pushing data and duplicating data, it will be on-demand. Also, because of the Cures Act, it will open up data using APIs. Having FHIR APIs in the cloud, it will allow apps to access EHR data in real-time.Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Guest Linkedin: Dr. Michael FarmerCoverix Website: https://corverix.com/pages/wearablesMusic Provided by Soundstripe.comLinkedin: Vik PatelLinkedin: Jimmy KimSupport the show (http://www.thisweekinhealthtech.com/)

Eric Wood from Omnicare reviews the next iteration of the Vivage Therapeutic Substitution form that will again require wet signature approval by everyone. He also discusses any notable changes since the last time we did this. The majority of the meeting is spent discussing what was a poorly advertised portion of the CURES Act. On November 2, a new federal rule that is part of the CURES Act requires the immediate release of many patient records including provider and non-provider daily progress notes (both inpatient and outpatient), plus all laboratory, radiology and pathology reports. This may have enormous implications for all of us, so this will be more of an open discussion than a presentation. References: "Centura Open Records Notification P1", Centura, Oct. 23, 2020. "Centura Open Records Notification P2", Centura, Oct. 23, 2020. "New Open Records Regulation". "Open Records Suggestions", UCHealth, Oct. 2020. Recorded on: 11/5/2020 Available Credit: 0.25 CMD-Clinical

In this episode of TWIHT we focus on the ONC's Cures Act Final act which is all about "Empowering Patients with Their Health Record in a Modern Health IT Economy".The ONC Cures Act Final Rule implements interoperability requirements outlined in the Cures Act. Vik and Jimmy jump into the details about how this Act helps Patients. Putting the patient first in health technology enables the health care system to deliver:Transparency into the cost and outcomes of their careCompetitive options in getting medical careModern smartphone apps to provide them convenient access to their recordsAn app economy that provides patients, physicians, hospitals, payers, and employers with innovation and choiceVik mentions about the API access that has already been enabled by EHRs and how it is allowing patients to access their health information on iPhone and Android devices. Vik indicates that this ruling will spur up an App Economy, starting from purchasing a health service by comparing services and pricing provided by healthcare providers. Another example would be the way information would be available to patients instead of the standard patient portal, where understanding the health / medical record is not very easy for most patients. This is going to promote better health and better outcomes since it puts patients first. Jimmy comments that this does sound amazing for patients but could be bad for bad performing clinics and hospitals. Vik said it will definitely increase patient quality because now the data available will show patient outcomes for every provider. Vik and Jimmy also discuss privacy and security concerns. Vik discusses that you still need to follow the security protocols, OAuth2 to access patient information. There is also governance and authorization and it's not just open data. Vik compares it to banking budgeting apps that have to be authorized by the user and also need a valid back-end connection with the bank. The same idea will be used with the FHIR API access in healthcare and privacy and security concerns will be addressed. Jimmy asks if everyone is for this ruling and Vik indicates that not everyone is. Big Tech (Microsoft, Apple, Google, Amazon), even more EHRs (Cerner, AllScripts, Meditech, etc). are for the ruling. Epic EHR did oppose this ruling based on patient privacy concerns. Vik comments that innovation is also going to benefit clinicians as the app economy will lead to the development of many apps for every service provided by healthcare. Jimmy and Vik also comment on few other examples including sharing medical record between clinicians and hospitals. Website: http://www.thisweekinhealthtech.comTwitter: @TWIHT1Tido Inc.: https://www.tidoinc.com/Music Provided by Soundstripe.comLinkedin: Vik PatelLinkedin: Jimmy KimSupport the show (http://www.thisweekinhealthtech.com/)Support the show (http://www.thisweekinhealthtech.com/)

This episode of The Exam Room is a deep dive into the ONC Cures Act Final Rule, the biggest healthcare law that no one's ever heard of. From what the law does to how it will change physician workflow, this editorial/rant offers a great overview peppered with Dr. V's analysis and insight. Important Links: https://33charts.com/cures-act-final-rule/ Learn more about your ad choices. Visit megaphone.fm/adchoices

The CyberPHIx Roundup is your quick source for keeping up with the latest cybersecurity news, trends and industry leading practices, specifically for the healthcare industry. In this episode, our host Brian Selfridge highlights the following topics trending in healthcare cybersecurity this week: Telehealth adoption trends and highlights from a new KLAS report released this week Lessons learned from a recently reported breach event for a telehealth app Federal HIPAA and state exemption extensions and modifications related to telehealth platforms and recommendations for steps that healthcare providers can take to secure telehealth platforms 21st Century Cures Act enforcement, fines, and technical integration and security mandates Smart phone app integration standards for EHRs as part of the Cures Act including HL7's FHIR standard, EHR and app development progress, and related security requirements and recommendations for healthcare entities

Featuring articles on oral lopinavir-ritonavir for severe Covid-19, ruxolitinib for acute graft-vs.-host disease, emapalumab in hemophagocytic lymphohistiocytosis, infections with resterilized cardiac implanted devices, and mitochondrial replacement in infertility; a review article on Ebola; a Clinical Problem-Solving describing hiding in the water; and Perspective articles on importing prescription drugs from Canada, on implementing the Cures Act, and on fear and the front line.

  Graphic courtesy of CASATunr/VimeoE Electronic visit verification is a component of the 21st century CURES Act of 2016. It was a sneaky little poison pill added to the act and no one likes it…Except those who believe workers and recipients are ALL fraudulent pirates who MUST BE STOPPED! It will affect all in-home care programs including California's In-Home Supportive Services (IHSS). And, if states do not implement it, they'll lose critical funding for Medicaid (that's Medi-Cal in California). Many states have already begun implementation of this federal requirement with many Orwellian results, so workers and recipients in California are VERY concerned about what the future will look like for people with disabilities. There is yet hope! Our privacy protectors have already won an important delay in the start date and they are working on long term fixes. Hannah Karpilow, a home care worker, and Marissa Shaw, a recipient of in-home supportive services and Supportive Living Services join Sheela Gunn-Cushman and Alysa Chadow to discuss this prickly complex issue. Community Forum and Roundtable Discussions Bay Area – Berkeley Monday, April 23,  3-4:30 pm Ed Roberts Campus 3075 Adeline St.  Berkeley Sacramento Tuesday, April 24, 4-6 pm SEIU Local 2015 West Sacramento Office 691 W. Capitol Ave, West Sacramento Los Angeles Thursday, April 26, 4-6 pm SEIU Local Headquarters 2910 Beverly Blvd, Los Angeles The only entities benefiting from this EVV mandate are the EVV vendors! Richard Daggett, President, Polio Survivors Association Member, American Academy of Home Care Medicine richard@polioassociation.org The post IHSS Electronic Visit Verification: All We Know – and the things we don't appeared first on KPFA.

2017 was a whirlwind year for health care policy and change. We watched as the drama of the ACA repeal and replace conversation has twisted and turned, we heard the troubling statistics related to the opioid crisis and we are now on the cusp of a tax reform bill and the implementation of the Cures Act – both of which have implications for the health care industry. That’s a lot to chew on. In this episode of The Cerner Podcast, Meg Marshall helps us understand these moving pieces and what they mean for the health care industry. Meg is the senior director of public policy at Cerner, where she has spearheaded important policy changes to improve health care for consumers.

The 21st Century Cures act was passed in December 2016 with the goal of improving EHR interoperability through information blocking provisions and streamlining of standards development. It’s legislature intended to have real and immediate impact on the health IT industry. In this episode of The Cerner Podcast, we're joined by Dr. Donald Rucker, the national coordinator for Health Information Technology. The ONC is considered the beating heart of American health care policy, and one of its primary platforms is the promotion of nationwide health information exchange to improve health care. In this episode, Rucker will discuss the health IT provisions in the 21st Century Cures Act and what else we can look for from the ONC.

Photo by Long Beach Residents Empowered Tenants gathered at a Statewide Renters Assembly in Alameda over the weekend.  Ava and Fernando Nadal were there, gearing up to lead an attack on the landlord demon law, Costa Hawkins*.  This, despite the impending loss of their home and Fernando's upcoming major Ava & Fernando Nadal. Photo by Ridge Gonzalez, L.A. Eviction Defense Network surgery.  Adrienne Lauby talks with them. If you've been asked to “tell your story” to a funder or politician, stick around for Sheela Gunn-Cushman's essay.  If you've ever asked a consumer, client or constituent to “tell your story,” you must listen as Sheela explores the grueling, degrading and thankless nature of this activist tool many of us rely on. *Costa Hawkins is a state-wide law that limits the number, type and age of homes that can be covered by rent control.  It was passed in the late '90s at the request of landlord and realtor groups.  Local groups working for rent control and just cause eviction find it a major barrier to success. Protest of AirBnB Hats off to a coalition of advocates for disabled people, seniors and tenants who rallied at the San Francisco headquarters of Airbnb on Oct.19.   Despite Airbnb's $30 billion dollar market value, Airbnb's hosts routinely discriminate against people with disabilities.   There's nothing innovative or disruptive about discrimination, and there's no law protecting a ‘platform's' right to embrace it.” Bob Planthold said, “Airbnb is a dominant player in the travel industry. It's past time for the corporation to assume responsibility for ensuring all travelers have access to its accommodations.” For more on this issue, contact Senior and Disability Action in San Francisco. Their phone is (415) 546-1333. IHSS Draconian Restrictions Due to new Federal requirements in the CURES Act, California will soon monitor the coming and going of In-Home Supportive Services (IHSS) recipients and our care providers with some form of a call-in system for monitoring and tracking when an IHSS recipient's care provider arrives to clock in and out for work, verifies the presence of the IHSS recipient, verifies or tracks the location of the recipient, and demands to know the services (tasks) rendered or delivered to the IHSS recipient during the providers' working hours. There will be a series of stakeholder meetings in Sacramento to help plan these changes.  This is the first one: Thursday, Oct. 12 10 a.m.-noon CDSS, 744 P St., Sacramento. OB 8, Room 235/237 If you plan to attend in person, please RSVP to jeffrey.berndt@dss.ca.gov To attend by phone, contact: Kim Rutledge at Kim.Rutledge@dss.ca.gov Those of us with disabilities who are IHSS recipients should look at these regulations and provide input and feedback as we will be impacted by this Big Brother regulatory oversight of our lives. We can only presume that this paternalistic approach to monitoring the coming and going of our IHSS providers (and waiver providers) will result in an infringement of our freedom of mobility and how we will be forced to live our lives on a short leash or under some adverse system of tracking with calling in or out similar to a criminal wearing an ankle bracelet. If the state fails to comply with these new regulations, the state will lose federal funding. Axis Dance Hold the last weekend of Oct. The disabled and non-disabled, mixed-ability group, Axis Dance, is celebrating their 30th anniversary with performances titled “Onward and Upward.” It's a program of three dances, including one by their new Artistic Director, Mark Brew. That one was created in collaboration with JooWan Kim, artistic director of the Hip-Hop Orchestra. That's Axis Dance performances — the last week of October. ——- This program produced and hosted by Sheela Gunn-Cushman and Adrienne Lauby. The post Renters Assemble & “Telling My Story” appeared first on KPFA.

Legislation that would provide incentives to drugmakers to repurpose existing pharmaceuticals as rare disease treatments is once again in the works. Known as The OPEN ACT (Orphan Product Extensions Now, Accelerating Cures and Treatments), proponents say it would help address a gap in the drug development landscape. At one point, the bill had been folded into the 21st Century Cures Act, but had been stripped out before passage. We spoke to Max Bronstein, chief advocacy and science policy officer for the Everylife Foundation for Rare Diseases, about the legislation, why its needed, and what it will take to get passed.

Former Congressman Tom Price is our new Secretary of Health and Human Services, making him the chief law enforcement officer of health care policy in the United States. In this episode, hear highlights from his Senate confirmation hearings as we search for clues as to the Republican Party plans for repealing the Affordable Care Act. We also examine the 21st Century Cures Act, which was signed into law in December. Please support Congressional Dish: Click here to contribute with PayPal or Bitcoin Click here to support Congressional Dish for each episode via Patreon Mail Contributions to: 5753 Hwy 85 North #4576 Crestview, FL 32536 Thank you for supporting truly independent media! Recommended Congressional Dish Episodes CD048: The Affordable Care Act (Obamacare) CD123: Health or Profits Bill Outline H.R. 34: 21st Century Cures Act Bill Highlights Title I: Innovation Projects & State Response to Opioid Abuse Authorizes funding for research programs, if money is appropriated Authorizes $1 billion for grants for States to deal with the opioid abuse crisis The effects of this spending on the Pay as you Go budget will not be counted Title II: Discovery Creates privacy protections for people who participate as subjects in medical research studies Orders the Secretary of Health and Human Services to a do a review of reporting regulations for researchers in search of regulations to cut, including regulations on reporting financial conflicts of interest and research animal care. Allows contractors to collect payments on behalf of the Secretary of Health and Human Services Title III: Development Gives the Secretary of Health and Human Services additional data options for approving drug applications Expedites the review process for new "regenerative advanced therapy" drugs, which includes drugs "intended to treat, modify, reverse or cure a serious or life-threatening disease or condition" or is a therapy that involves human cells. Allows antibacterial and antifungal drugs to be approved after only being tested on a "limited population" The drugs will have have a "Limited Population" label Speeds up the FDA approval process for new medical devices that help with life-threatening or irreversibly debilitating conditions and that have no existing alternatives. Devices addressing rare diseases or conditions are allowed be approved with lower standards for effectiveness; this provision expands the definition of "rare" by doubling the number of people affected from 4,000 to 8,000. Each FDA employee involved in drug approvals will get training for how to make their reviews least burdensome. Title IV: Delivery The new Secretary of Health and Human Services will have to develop a strategy to "reduce regulatory and administrative burdens (such as doucmentation requirements) relating to the use of electronic health records" Prohibits health information technology developers from certification if their system allows information blocking. Developers, networks, or exchanges caught blocking information can be fined $1 million per violation. "Public-private partnerships" will develop the rules for exchanging health record information. Creates a job in the Medicare & Medicaid Services department for an investigator of pharmaceutical and medical device manufacturer complaints. Title V: Savings Reduced funding for the Prevention and Public Health Fund Sells more oil from the Strategic Petroleum Reserve Title VII: Ensuring Mental and Substance Use Disorders Prevention, Treatment, and Recovery Programs Keep Pace With Technology Authorizes money to be used for mental health services and substance abuse treatment Title IX: Promoting Access to Mental Health and Substance Use Disorder Care Creates a telephone and online service to help people locate mental health services and substance abuse treatment centers. Title XIV: Mental health and safe communities Creates a pilot program to test the idea of having court cases with mentally ill defendants heard in "drug or mental health courts" Title XVII: Other Medicare Provisions Prevents the government from canceling contracts with Medicare Advantage organizations due to their failure to achieve a minimum quality rating before 2019. Additional Reading Article: Trump's HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm by Jay Hancock and Rachel Bluth, Kaiser Health News, February 13, 2017. Article: Tom Price belongs to a doctors group with unorthodox views on government and health care by Amy Goldstein, The Washington Post, February 9, 2017. Article: New stock questions plague HHS nominee Tom Price as confirmation vote nears by Jayne O'Donnell, USA Today, February 8, 2017. Article: HHS Pick Price Made 'Brazen' Stock Trades While His Committee Was Under Scrutiny by Marisa Taylor and Christina Jewett, Kaiser Health News, February 7, 2017. Article: Tom Price, Dr. Personal Enrichment by David Leonhardt, The New York Times, February 7, 2017. Article: Donald Trump's Cabinet Pick Invested in 6 Drug Companies Before Medicare Fight by Sam Frizell, TIME, January 17, 2017. Article: First on CNN: Trump's Cabinet pick invested in company, then introduced a bill to help it by Manu Raju, CNN, January 17, 2017. Publication: How Repealing Portions of the Affordable Care Act Would Affect Health Insurance Coverage and Premiums, Congressional Budget Office, January 17, 2017. Article: Under 21st Century Cures legislation, stem cell advocates expect regulatory shortcuts by Kelly Servick, Science, December 12, 2016. Article: Highlights of Medical Device Related Provision in the 21st Century Cures Act by Jeffrey K. Shapiro and Jennifer D. Newberger, FDA Law Blog, December 8, 2016. Article: Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes by Sheila Kaplan, STAT, November 27, 2016. Article: Introduction to Budget "Reconciliation" by David Reich and Richard Kogan, Center on Budget and Policy Priorities, November 9, 2016. Article: PhRMA companies push hard on House bill to ease testing of new drugs by Alex Lazar, OpenSecrets.org, June 16, 2015. References Financial Disclosure: Periodic Transaction Report: Thomas Price, United States House of Representatives, September 6, 2016. OpenSecrets: Senator Mitch McConnell 42 U.S. Code: Office of the National Coordinator for Health Information Technology, Cornell University Law School. Senate Vote: H.R. 34: 21st Century Cures Act Innate Immunotherapeutics:Top 20 Shareholders Innate Immunotherapeutics: Company Overview GovTrack: H.R. 4848 (114th): HIP Act Sound Clip Sources Hearing: Health and Human Services Secretary Confirmation, Senate Health, Education, Labor and Pensions Committee, January 18, 2017 (Part 1) and January 24, 2017 (Part 2). Watch on CSPAN Part 1 Part 2 Timestamps & Transcripts Part 1 47:45 Senator Patty Murray: I want to review the facts. You purchased stock in Innate Immunotherapeutics, a company working to develop new drugs, on four separate occasions between January 2015 and August 2016. You made the decision to purchase that stock, not a broker. Yes or no. Tom Price: That was a decision that I made, yes. Murray: You were offered an opportunity to purchase stock at a lower price than was available to the general public. Yes or no. Price: The initial purchase in January of 2015 was at the market price. The secondary purchase in June through August, September of 2016 was at a price that was available to individuals who were participating in a private-placement offering. Murray:It was lower than was available to the general public, correct? Price: I don’t know that it was. It was the same price that everybody paid for the private-placement offering. Murray: Well, Congressman Chris Collins, who sits on President-elect Trump’s transition team, is both an investor and a board member of the company. He was reportedly overheard just last week off the House floor, bragging about how he had made people millionaires from a stock tip. Congressman Price, in our meeting, you informed me that you made these purchases based on conversations with Representative Collins. Is that correct? Price: No. What I— Murray: Well, that is what you said to me in my office. Price: What I believe I said to you was that I learned of the company from Congressman Collins. Murray: What I recall our conversation was that you had a conversation with Collins and then decided to purchase the stock. Price: No, that’s not correct. Murray: Well, that is what I remember you hearing it—say—in my office. In that conversation, did Representative Collins tell you anything that could be considered “a stock tip?” Yes or no. Price: I don’t believe so, no. Murray: Well, if you’re telling me he gave you information about a company, you were offered shares in the company at prices not available to the public, you bought those shares, is that not a stock tip? Price: Well, that’s not what happened. What happened was that he mentioned—he talked about the company and the work that they were doing in trying to solve the challenge of progressive secondary multiple sclerosis which is a very debilitating disease and one that I— Murray: I’m well aware of that, but— Price: —had the opportunity to treat patients when I was in practice. Murray: I’m aware— Price: I studied the company for a period of time and felt that it had some significant merit and promise, and purchased the initial shares on the stock exchange itself. Murray: Congressman Price, I have very limited time. Let me go on. Your purchases occurred while the 21st Century Cures Act, which had several provisions that could impact drug developers like Innate Immunotherapeutics, was being negotiated, and, again, just days before you were notified to prepare for a final vote on the bill. Congressman, do you believe it is appropriate for a senior member of Congress actively involved in policymaking in the health sector to repeatedly personally invest in a drug company that could benefit from those actions? Yes or no. Price: Well, that's not what happened. 1:06:50 Senator Bernie Sanders: The United States of America is the only major country on earth that does not guarantee healthcare to all people as a right. Canada does it; every major country in Europe does it. Do you believe that healthcare is a right of all Americans, whether they’re rich or they’re poor? Should people, because they are Americans, be able to go to the doctor when they need to, be able to go into a hospital, because they are Americans? Tom Price: Yes. We’re a compassionate society— Sanders: No, we are not a compassionate society. In terms of our relationship to poor and working people, our record is worse than virtually any other country on earth; we have the highest rate of childhood poverty of any other major country on earth; and half of our senior, older workers have nothing set aside for retirement. So I don’t think, compared to other countries, we are particularly compassionate. But my question is, in Canada, in other countries, all people have the right to get healthcare, do you believe we should move in that direction? Price: If you want to talk about other countries’ healthcare systems, there are consequences to the decisions that they’ve made just as there are consequences to the decision that we’ve made. I believe, and I look forward to working with you to make certain, that every single American has access to the highest-quality care and coverage that is possible. Sanders: “Has access to” does not mean that they are guaranteed healthcare. I have access to buying a ten-million-dollar home; I don’t have the money to do that. Price: And that’s why we believe it’s appropriate to put in place a system that gives every person the financial feasibility to be able to purchase the coverage that they want for themselves and for their family, again, not what the government forces them to buy. Sanders: Yeah, but if they don’t have any—well, it’s a long dissert. Thank you very much. Price: Thank you. 1:46:34 Senator Michael Bennet: So, I ask you, sir, are you aware that behind closed doors Republican leadership wrote into this bill that any replacement to the Affordable Care Act would be exempt from Senate rules that prohibit large increases to the deficit? Tom Price: As you may know, Senator, I stepped aside as chairman of the budget committee at the beginning of this year, and so I wasn’t involved in the writing of— Bennet: You have been the budget committee chairman during the rise of the Tea Party; you are a member of the Tea Party Caucus; you have said over and over again, as other people have, that the reason you’ve come to Washington is to reduce our deficit and reduce our debt. I assume you’re very well aware of the vehicle that is being used to repeal the Affordable Care Act. This is not— Price: Yes. Bennet: —some small piece of legislation. This is the Republican budget. Price: Yes, I'm aware of the bill. Yes. Bennet: But do you support a budget that increases the debt by $10 trillion? Price: No. What I support is an opportunity to use reconciliation to address the real challenges in the Affordable Care Act and to make certain that we put in place at the same time a provision that allows us to move the healthcare system in a much better direction— Bennet: Do you support the budget that was passed by the Senate Republicans— Price: I support— Bennet:—to repeal the Affordable Care Act that adds $10 trillion of debt to the budget deficit? Price: Well, the reconciliation bill is yet to come. I support the process that allows for and provides for the fiscal year ’17 reconciliation bill to come forward. 2:38:37 Senator Chris Murphy: But do you direct your broker around ethical guidelines? Do you tell him, for instance, not to invest in companies that are directly connected to your advocacy? Because it seems like a great deal: as a broker, he can just sit back, take a look— Tom Price: She. Murphy: —at the positions that you’re taking— Price: She. She can sit back. Murphy: She can—she can sit back— Price: Yeah. Murphy: —in this case—look at the legislative positions you’re taking, and invest in companies that she thinks are going to increase in value based on your legislative activities, and you can claim separation from that because you didn’t have a conversation. Price:Well, that’s a nefarious arrangement that I’m really astounded by. The fact of the matter is that I have had no conversations with my broker about any political activity at all, other than her— Murphy: Then why wouldn’t you tell her— Price: —other than her congratulating— Murphy: Why— Price: —me on my election. Murphy: But why wouldn’t you at least tell her, “Hey, listen; stay clear of any companies that are directly affected by my legislative work”? Price: Because the agreement that we have is that she provide a diversified portfolio, which is exactly what virtually every one of you have in your investment opportunities, and make certain that in order to protect one’s assets that there’s a diversified arrangement for purchase of stocks. I knew nothing about— Murphy: But you couldn’t have— Price: —those purchases. Murphy: But you couldn’t have a diversified portfolio while staying clear of the six companies that were directly affected by your work on an issue? Price: Well, as I said, I didn’t have any knowledge of those purchases. Murphy: Okay. 2:54:20 Senator Elizabeth Warren: One of the companies—it’s the company raised by Mr. Franken, Senator Franken—and that is Zimmer Biomet. They’re one of the world’s leading manufacturers of hip and knees, and they make more money if they can charge higher prices and sell more of their products. The company knows this, and so do the stock analysts. So on March 17, 2016 you purchased stock in Zimmer Biomet. Exactly six days after you bought the stock, on March 23, 2016, you introduced a bill in the House called the Hip Act that would require HHS secretary to suspend regulations affecting the payment for hip and knee replacements. Is that correct? Tom Price: I think the BPCI program to which I think you referred I’m a strong supporter of because it keeps the decision making in the— Warren: I’m not asking you about why you support it. I’m just asking, did you buy the stock, and then did you introduce a bill that would be helpful to the companies you just bought stock in? Price: The stock was bought by a direct—by a broker who was making those decisions. I wasn’t making those decisions. Warren: Okay, so you said you weren’t making those decisions. Let me just make sure that I understand. These are your stock trades, though. They are listed under your name, right? Price: They’re made on my behalf, yes. Warren:Okay. Was the stock purchased through an index fund? Price: I don't believe so. Warren: Through a passively managed mutual fund? Price: No. It’s a broker— Warren: Through an actively managed mutual fund? Price: It’s a broker-directed account. Warren: Through a blind trust? So, let’s just be clear. This is not just a stockbroker, someone you pay to handle the paperwork. This is someone who buys stock at your direction. This is someone who buys and sells the stock you want them to buy and sell. Price: Not true. Warren: So when you found out that— Price: That’s not true, Senator. Warren: Well, because you decide not to tell them—wink, wink, nod, nod—and we’re all just supposed to believe that? Price: It’s what members of this committee, it’s the manner of which— Warren: Well, I’m not one of them. Price: —members of this committee—Well, I understand that— Warren: So, let me just keep asking about this. Price: —but it’s important to appreciate that that’s the case. Warren:Then, I want to understand. When you found out that your broker had made this trade without your knowledge, did you reprimand her? Price: What—what I did was comply— Warren: Well, you found out that she made it. Price: What I did was comply— Warren: Did you fire her? Did you sell the stock? Price: What I did was comply with the rules of the House in an ethical and legal and— Warren: I didn’t ask whether or not the rules of the House— Price: —above-board manner— Warren: —let you do this. Price: —and in a transparent way. Warren: You know, all right. So, your periodic transaction report notes that you were notified of this trade on April 4, 2016. Did you take additional actions after that date to advance[audio cuts out] the company that you now own stock in? Price: I’m offended by the insinuation, Senator. Warren: Well, let me just read what you did. You may be offended, but here’s what you did. Congressional records show that after you were personally notified of this trade, which you said you didn’t know about in advance, that you added 23 out of your bill’s 24 co-sponsors; that also after you were notified of this stock transaction, you sent a letter to CMS, calling on them to cease all current and future planned mandatory initiatives under the Center for Medicare and Medicaid Innovation; and just so there was no misunderstanding about who you were trying to help, you specifically mentioned— Unknown Speaker: Your two minutes are up, Senator Warren. Thank you. Warren: —hip and knee replacement. 2:58:20 Senator Johnny Isakson: This is very important for us to all understand under the disclosure rules that we have and the way it operates, any of us could make the mistakes that are being alleged. I’m sure Senator Franken had no idea that he owned part of Philip Morris when he made the statement he made about tobacco companies, but he has a WisdomTree Equity Income Fund investment, as disclosed in his disclosure, which owns Philip Morris. So, it’s entirely possible for any of us to have somebody make an investment on our behalf and us not know where that money is invested because of the very way it works. I don’t say that to, in any way, embarrass Mr. Franken but to make a point that any one of us who have mutual funds or investment managers or people who do that, it’s entirely possible for us not to know, and to try and imply that somebody’s being obfuscating something or in otherwise denying something that’s a fact, it’s just not the fair thing to do, and I just wanted to make that point. Senator Al Franken: This is different than mutual funds. Isakson: It’s an investment in Philip Morris. Unknown Speaker: Alright. Unknown Speaker: Thank you. Warren: And my question was about what do you do after he had notice. Unknown Speaker: Senator Warren, your time has been generously… Senator Kaine. 3:21:09 Senator Tim Kaine: Do you agree with the president-elect that the replacement for the Affordable Care Act must ensure that there is insurance for everybody? Tom Price: I have stated it here and— Kaine: Right. Price: —always that it’s incredibly important that we have a system that allows for every single American to have access to the kind of coverage that they need and desire. Kaine: And he’s— 3:31:52 Senator Patty Murray: You admitted to me in our meeting that you, in your own words, talked with Congressman Collins about Innate Immuno. This inspired you to you, in your own words, study the company and then purchase its stock, and you did so without a broker. Yes or no. Tom Price: No. Murray: Without a broker. Price: I did not. Murray: You told me that you did this one on your own without the broker. Yes? Price: No, I did it through a broker. I directed the broker to purchase the stock, but I did it through a broker. Murray: You directed the broker to purchase particularly that stock. Price: That's correct. Murray: Yeah. 3:34:42 Senator Patty Murray: Will you commit to ensuring all 18 FDA-approved methods of contraception continue to be covered so that women do not have to go back to paying extra costs for birth control? Tom Price: What I will commit to and assure is that women and all Americans need to know that we believe strongly that every single American ought to have access to the kind of coverage and care that they desire and want. 3:36:38 Senator Patty Murray: The Office of Minority Health was reauthorized as part of the ACA. So will you commit to maintaining and supporting this office and its work? Tom Price: I will commit to be certain that minorities in this country are treated in a way that makes certain—makes absolutely certain—that they have access to the highest-quality care. Murray: So you will not commit to the Office of Minority Health being maintained. Price: I think it’s important that we think about the patient at the center of all this. Our commitment, my commitment, to you is to make certain that minority patients and all patients in this country have access to the highest-quality care. Murray: But in particular—so you won’t commit to the Office of Minority— Price: We—Look, there are different ways to handle things. I can’t commit to you to do something in a department that one, I’m not in—I haven’t gotten it yet— Murray: But you will be. Price: —and— Murray: You will be, and— Price: Let me put forward a possible position that I might find myself in. The individuals within the department come to me and they say, we’ve got a great idea for being able to find greater efficiencies within the department itself, and it results in merging this agency and that agency— Murray: I think—I think that— Price: —and we’ll call it something else. Murray: Yeah. I—okay. Price: And we will address the issues of minority health— Murray: I just have a minute left, and I hear your answer. Price: —in a big, big way— Murray: You’re not committed, okay. Price: —and make certain that it is responsive to patients. Part 2 14:50 Senator Ron Wyden: Congressman Price owns stock in an Australian biomedical firm called Innate Immunotherapeutics. His first stock purchase came in 2015 after consulting Representative Chris Collins, the company’s top shareholder and a member of its board. In 2016 the congressman was invited to participate in a special stock sale called a private placement. The company offered the private placement to raise funds for testing on an experimental treatment it intends to put up for FDA approval. Through this private placement, the congressman increased his stake in the company more than 500 percent. He has said he was unaware he paid a price below market value. It is hard to see how this claim passes the smell test. Company filings with the Australia’s stock exchange clearly state that this specific private placement would be made at below-market prices. The treasury department handbook on private placement states, and I will quote, they “are offered only to sophisticated investors in a nonpublic manner.” The congressman also said last week he directed the stock purchase himself, departing from what he said was typical practice. Then, there’s the matter of what was omitted from the congressman’s notarized disclosures. The congressman’s stake in Innate is more than five times larger than the figure he reported to ethic’s officials when he became a nominee. He disclosed owning less than $50,000 of Innate stock. At the time the disclosure was filed, by my calculation, his shares had a value of more than $250,000. Today his stake is valued at more than a half million dollars. Based on the math, it appears that the private placement was excluded entirely from the congressman’s financial disclosure. This company’s fortunes could be affected directly by legislation and treaties that come before the Congress. 30:49 Senator Orrin Hatch: First, is there anything that you are aware of in your background that might present a conflict of interest with the duties of the office to which you have been nominated? Tom Price: I do not. 51:36 Senator Ron Wyden: Will you commit to not implementing the order until the replacement plan is in place? Tom Price: As I mentioned, Senator, what I commit to you and what I commit to the American people is to keep patients the center of healthcare, and what that means to me is making certain that every single American has access to affordable health coverage that will provide the highest-quality healthcare that the world can provide. 1:24:34 Senator Richard Burr: Are you covered by the STOCK Act, legislation passed by Congress that requires you and every other member to publicly disclose all sales and purchases of assets within 30 days? Tom Price: Yes, sir. Burr: Now, you’ve been accused of not providing the committee of information related to your tax and financial records that were required of you. Are there any records you have been asked to provide that you have refused to provide? Price: None whatsoever. Burr: So all of your records are in. Price: Absolutely. Burr: Now, I’ve got to ask you, does it trouble you at all that as a nominee to serve in this administration that some want to hold you to a different standard than you as a member of Congress, and I might say the same standard that they currently buy and sell and trade assets on? Does it burn you that they want to hold you to a different standard now that you’re a nominee than they are as a member? Price: Well, I—we know what’s going on here. Burr: Oh, we do. Price: I mean— Burr: We do. Price: It’s—and I understand. And as my wife tells me, I volunteered for this, so… 1:26:49 Senator Richard Burr: As the nominee and hopefully—and I think you will be—the secretary of HHS, what are the main goals of an Obamacare replacement plan? Tom Price: Main goals, as I mentioned, are outlined in those principles, that is imperative that we have a system that’s accessible for every single American; that’s affordable for every single American; that is incentivizes and provides the highest-quality healthcare that the world knows; and provides choices to patients so that they’re the ones selecting who’s treating them, when, where, and the like. So it’s complicated to do, but it’s pretty simple stuff. 1:34:58 Senator Johnny Isakson: Any one of us can take a financial disclosure—and there’s something called desperate impact, where you take two facts—one over here and one over there—to make a wrong. Any one of us could do it to disrupt or misdirect people’s thoughts on somebody. It’s been happening to you a lot because people have taken things that you have disclosed and tried to extrapolate some evil that would keep you from being secretary of HHS when, in fact, it shouldn’t be true. For example, if you go to Senator Wyden’s annual report, he owns an interest in BlackRock Floating Rate Income Fund. The major holding of that fund is Valeant Pharmaceuticals. They’re the people we jumped all over for 2700 percent increases last year in pharmaceutical products. But we’re not accusing the ranking member of being for raising pharmaceutical prices, but you could take that extrapolation out of that and then indict somebody and accuse them. Is that not true? 1:51:30 Senator Michael Bennet: I wonder whether you also believe that it’s essential that there be a floor for insurance providers. You know, some of the things that the Affordable Care Act require for coverage include outpatient care; emergency services; hospitalization; maternity and newborn care; prescription drugs; rehab services; lab services; preventative care, such as birth control and mammograms; pediatric services, like vaccines; routine dental exams for children younger than 19. I’m not going to ask you to go through each one of those, but directionally, are we headed to a world where people in rural America have to settle for coverage for catastrophic care; are we headed to a place where there is regulation of insurance providers that say if you are going to be an insurance market, you need—particularly if we’re in a world where your son had crossed state lines —there has to be a floor of the services you’re willing to pay for? Tom Price: I think there has to be absolutely credible coverage, and I think that it’s important that the coverage—that individuals ought to be able to purchase this coverage that they want. 1:56:45 Senator Pat Toomey: When we talk about repeal, sometimes I hear people say, well, we’ve got to keep coverage of pre-existing conditions because, you know, we’ve got to keep that. And when I hear that, I think that we’re missing something here, and here’s what I’m getting at. There’s obviously a number of Americans who suffer from chronic, expensive healthcare needs. They’ve had these conditions sometimes all their lives, sometimes for some other period of time. And for many of them the proper care for those conditions is unaffordable. I think we agree that we want to make sure those people get the healthcare they need. Now, one way to force it is to force insurance companies to provide health-insurance coverage for someone as soon as they show up, regardless of what condition they have, which is kind of like asking the property casualty company to rebuild the house after it’s burned down. But that’s only one way to deal with this, and so am I correct: is it your view that there are other perhaps more effective ways—since, after all, Obamacare’s in a collapse—to make sure that people with these pre-existing chronic conditions get the healthcare that they need at an affordable price without necessarily having the guaranteed-issue mandate in the general population? Tom Price: I think there are other options, and I think it’s important, again, to appreciate that the position that we currently find ourselves in, with policy in this nation, is that those folks, in a very short period of time, are going to have nothing because of the collapse of the market. 2:18:05 Tom Price: Every single individual ought to be able to have access to coverage. 2:29:45 Senator Tim Scott: My last question has to do with the employer-sponsored healthcare system that we’re so accustomed to in this country, that provides about 175 million Americans with their insurance. In my home state of South Carolina, of course, we have about two and a half million people covered by their employer coverage. If confirmed as HHS secretary, how would you support American employers in their effort to provide effective family health coverage in a consistent and affordable manner? Said differently, there’s been some conversation about looking for ways to decouple having health insurance through your employer. Tom Price: I think the employer system has been absolutely a remarkable success in allowing individuals to gain coverage that they otherwise might not gain. I think that preserving the employer system is imperative. That being said, I think that there may be ways in which individual employers—I’ve heard from employers who say, if you just give me an opportunity to provide my employee the kind of resources so that he or she is able to select the coverage that they want, then that makes more sense to them. And if that works from a voluntary standpoint for employers and for employees, then it may be something to look at. Scott: That would be more like the HRA approach where— Price: Exactly. Scott: —employer funds an account, and the employee chooses the health insurance, not necessarily under the umbrella of the employer specifically. Price: Exactly. And gains the same tax benefit. 2:58:00 Tom Price: What I’m for is making certain, again, that the Medicaid population has access to the highest-quality care possible, and we’ll do everything to improve that because right now so many in the Medicaid population don’t have access to the highest-quality care. 3:20:50 Tom Price: Our goal is to make certain that seniors have access to the highest-quality healthcare possible at an affordable price. Senator Bob Menendez: Well, access without the ability to afford it, and I’ll end on this— Price: That's what I said, affordable price. 3:28:45 Senator Sherrod Brown: If you and he are working together, are you going to suggest to him that we find a way in repeal and replace to make sure there is guaranteed healthcare for our nation’s veterans? Tom Price: Well, I think it’s vital, again, as I’ve mentioned before, that every single American have access to affordable coverage that’s of high quality, and that’s our goal, and that’s our commitment. 3:30:52 [regarding a disabled child coverd by Medicaid] Tom Price: We are absolutely committed to making certain that that child and every other child and every other individual in this nation has access to the highest-quality care possible. Senator Bob Casey Jr.: Okay, so not an access—he will have the medical care that he has right now or better—if you can come up with a better level of care, that’s fine—but he will have at least the coverage of Medicaid and all that that entails that he has right now. And that’s either a yes or no; that’s not— Price: No, it’s not a yes or no because the fact of the matter is that in order for the current law to change, you all have to change it— Casey: No, but here’s— Price: —and if I’m given the privilege of leading at the Department of Health and Human Services— Casey: Here’s why it’s yes— Price: and I respond to— Casey: You should stop talking around this. You have led the fight in the House, backed up by Speaker Ryan, for years— Price: To improve Medicaid. Casey: —to block grant Medicaid, okay? Price: To improve Medicaid. Casey: To block grant Medicaid. What that means is, states will have to decide whether or not this child gets the Medicaid that he deserves. That’s what happens. So you push it back to the states and hope it works out… Cover Art Design by Only Child Imaginations

The Obamacare repeal battle is THE story in health care, but it's not the only one. On a special edition of PULSE CHECK, five POLITICO health care reporters talk about what they're seeing ahead for the Affordable Care Act, and also drill down on other recent industry news. First, Pro's Jen Haberkorn and Rachana Pradhan (starts at the 2:15 mark) join Dan Diamond to discuss whether GOP plans to repeal Obamacare remain realistic, North Carolina's last-ditch push for Medicaid expansion, and who they're watching this frantic week. After the break, Pro's Paul Demko and Sarah Karlin-Smith (starts at 23:15) offer updates on the court battle over insurer mega-mergers, what the Cures Act could do for the pharma sector, and whether the health care industry will benefit or suffer under the Trump administration. *Note: Podcast was recorded before Monday night's moves in Congress to slow down Obamacare repeal efforts. We’d appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com.